# EDGAR Filing Document

**Accession Number:** 0000312069
**File Stem:** 0001654954-26-003973
**Filing Date:** 2026-4
**Character Count:** 153945
**Document Hash:** 12347c4c4f1d573d4f15cb16a877414a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-003973.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001654954-26-003973

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260428

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BARCLAYS PLC
- **CENTRAL INDEX KEY:** 0000312069
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMMERCIAL BANKS, NEC [6029]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-09246
- **FILM NUMBER:** 26903069

**BUSINESS ADDRESS:**
- **STREET 1:** 1 CHURCHILL PLACE
- **STREET 2:** CANARY WHARF
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** E14 5HP
- **BUSINESS PHONE:** 00442031340952

**MAIL ADDRESS:**
- **STREET 1:** 1 CHURCHILL PLACE
- **STREET 2:** CANARY WHARF
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** E14 5HP

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BARCLAYS BANK PLC
- **DATE OF NAME CHANGE:** 19850313

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BARCLAYS BANK LTD
- **DATE OF NAME CHANGE:** 19820607

 **UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, DC 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER**

 **PURSUANT TO RULE 13A-16 OR 15D-16**

 **UNDER THE SECURITIES EXCHANGE ACT OF 1934**

April 28, 2026

 **Barclays PLC**

(Name of Registrant)

 **1 Churchill Place**

 **London E14 5HP**

 **England**

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F

This Report on Form 6-K is filed by Barclays PLC.

This Report comprises:

Information given to The London Stock Exchange and furnished pursuant to

General Instruction B to the General Instructions to Form 6-K.

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BARCLAYS PLC <br> (Registrant)

Date: April 28, 2026

---

| |
|:---|
| By: /s/ Garth Wright<br> -------------------------------- |
| Garth Wright |
| Assistant Secretary |

---

 **Barclays PLC**

 **Q126 Results Announcement**

31 March 2026

 **Notes**

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2026 to the corresponding three months of 2025 and balance sheet analysis as at 31 March 2026 with comparatives relating to 31 December 2025 and 31 March 2025. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at <u>home.barclays/investor-relations.</u>

The information in this announcement, which was approved by the Board of Directors on 27 April 2026, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2025, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which does not make any statements under Section 498 of the Companies Act 2006) will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

These results will be furnished on Form 6-K to the US Securities and Exchange Commission (SEC) as soon as practicable following publication of this document. Once furnished to the SEC, a copy of the Form 6-K will be available from the SEC's website at <u>www.sec.gov</u>.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 **Non-IFRS performance measures**

Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 40 to 48 for definitions and calculations of non-IFRS performance measures included throughout this document, and reconciliations to the most directly comparable IFRS measures.

 **Forward-looking statements**

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including sustainability-related commitments and targets), plans and objectives for future operations, International Financial Reporting Standards ("IFRS") and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing sustainability reporting standards (including emissions accounting methodologies); changes in tax laws and practice; the outcome of current and future legal proceedings and regulatory investigations; the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively or navigate inconsistencies and conflicts in the manner in which climate policy is implemented in the regions where the Group operates, including as a result of the adoption of rules and regulations taking a different or opposing position on sustainability matters, or other forms of governmental and regulatory action against sustainability policies; environmental, social and geopolitical risks and incidents and similar events beyond the Group's control; financial crime; the impact of competition in the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; changes in trade policy, including the imposition of tariffs or other protectionist measures; the direct and indirect consequences of the conflicts in the Middle East and Ukraine on European and global macroeconomic conditions, political stability and financial markets; changes in US legislation and policy; developments in the UK's relationship with the European Union; the risk of cyberattacks, information or security breaches, technology failures or operational disruptions and any subsequent impact on the Group's reputation, business or operations; the use of new technology, including artificial intelligence; the Group's ability to access funding; and the success of acquisitions, disposals, joint ventures and other strategic transactions. A number of these factors are beyond the Group's control. As a result, the Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group's forward-looking statements. In setting its targets and outlook for the period 2026-2028, Barclays has made certain assumptions about the macroeconomic environment, including, without limitation, inflation, interest and unemployment rates, the different markets and competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs savings and other structural actions. Additional risks and factors which may impact the Group's future financial condition and performance are identified in Barclays PLC's filings with the US Securities and Exchange Commission ("SEC") (including, without limitation, Barclays PLC's Annual Report on Form 20-F for the financial year ended 31 December 2025), which are available on the SEC's website at <u>www.sec.gov</u>.

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 **Performance Highlights**

 ***For Q126, Barclays delivered a return on tangible equity (RoTE) of 13.5%, announced a £500m buyback and reiterated all 2026 and 2028 targets***

 ***C. S. Venkatakrishnan, Group Chief Executive, commented***

 *"Barclays delivered another solid quarter with a 13.5% RoTE in Q126, and double-digit returns in all our businesses. This was despite a one-off charge and impairments in the quarter. Top line income grew 6% year-on-year, driven by broad based divisional performance including in the Investment Bank, where we generated over £4bn quarterly income for the first time. The cost: income ratio improved to 56% and earnings per share (EPS) grew by 8% to 14.1p. Our capital position remains robust with a 14.1% common equity tier 1 (CET1) ratio and we are announcing a £500m buyback today. The breadth and quality of our businesses mean we remain confident in delivering all our financial targets across a range of environments. This includes greater than 12% RoTE in 2026 and greater than 14% RoTE in 2028."*

- Delivered £22bn of c.£30bn planned UK risk weighted assets (RWAs) growth since 2024¹, of which £15bn was organic growth

- Delivered c.£150m of gross cost efficiency savings in Q126

- As a result, Group LLR in FY26 is expected to be around the top of the 50-60bps through the cycle guidance range

- Taking into account the impact of the £500m share buyback announced today, the CET1 ratio as of 31 March 2026 would be reduced to 13.9%, at the top end of the 13-14% range

 **Key financial metrics:**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Income** | **Profit before tax** | **Attributable profit** | **Cost: income ratio** | **LLR** | **RoTE** | **EPS** | **CET1 ratio** | **Total capital return** |
| **Q126** | £8.2bn | £2.8bn | £1.9bn | 56% | 74bps | 13.5% | 14.1p<br> 405p | 14.1% | £0.5bn |

---

 **Q126 Performance highlights:**

- Barclays UK income increased 9%, as higher structural hedge income was partially offset by retail deposit dynamics

- Barclays UK Corporate Bank (UKCB) income increased 10%, reflecting higher average deposit and lending balances, and higher structural hedge income

- Barclays Private Bank and Wealth Management (PBWM) income was broadly stable, as growth from higher client balances was offset by the impact of deposit mix

- Barclays Investment Bank (IB) income increased 4%, driven by Global Markets and Investment Banking fees partially offset by the strengthening of average GBP against USD

- Barclays US Consumer Bank (USCB) income increased 14%, driven by business growth and increased purchase activity, partially offset by the strengthening of average GBP against USD

- Group operating costs increased 2% to £4.4bn, reflecting further investment spend, business growth and inflation, partially offset by c.£0.2bn of cost efficiency savings and FX movements

- Litigation and conduct charges of £0.1bn primarily reflected an increase in the provision for the UK Financial Conduct Authority (FCA) motor finance redress scheme

---

| | |
|:---|:---|
| *1* | *Represents RWAs from business growth in Barclays UK, UK Corporate Bank and Private Bank and Wealth Management since January 2024, excluding the effects of securitisations, model updates and other methodological changes. Also excludes additional Operational Risk RWAs related to organic growth.* |

---

 **Q126 Performance highlights (continued):**

● **Credit impairment charges were £0.8bn (Q125: £0.6bn**)
with an LLR of 74bps (Q125: 61bps), including a £0.2bn single
name charge in the IB

● **CET1 ratio of 14.1% (December 2025: 14.3%),** with
RWAs of £364.5bn (December 2025: £356.8bn). Tangible net
asset value (TNAV) per share of 405p (December 2025:
409p)

 **Group financial targets<sup>1</sup>:**

 **2026 targets**

- Progressive increase in total capital returns versus 2025

- Share buybacks announced quarterly

- Dividends to be paid semi-annually, including planned £2bn dividend for 2026

- Group NII excluding IB and Head Office greater than £13.5bn and Barclays UK NII of £8.1bn - £8.3bn

- IB RWAs mid 50s% of Group RWAs

- Impact of regulatory change on RWAs in line with our prior guidance of c.£19-26bn

- Expect Pillar 2A capital to reduce upon implementation of Basel 3.1 and USCB IRB

 **2028 targets**

- IB RWAs of c.50% of Group RWAs

---

| | |
|:---|:---|
| *1* | *Our targets and guidance are based on management's current expectations as to the macroeconomic environment and the business and may be subject to change.* |
| *2* | *This multi-year plan is subject to supervisory and Board approvals, anticipated financial performance and our published CET1 ratio target range of 13-14%.* |
| *3* | *Fundamental review of the trading book (FRTB) impact mostly expected in 2027.* |

---

---

| | | | |
|:---|:---|:---|:---|
| **Barclays Group results** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
|  | £m | £m | % Change |
| &nbsp;&nbsp;&nbsp; Barclays UK | 2258 | 2074 | 9 |
| &nbsp;&nbsp;&nbsp; Barclays UK Corporate Bank | 530 | 484 | 10 |
| &nbsp;&nbsp;&nbsp; Barclays Private Bank and Wealth Management | 347 | 349 | (1) |
| &nbsp;&nbsp;&nbsp; Barclays Investment Bank | 4028 | 3873 | 4 |
| &nbsp;&nbsp;&nbsp; Barclays US Consumer Bank | 983 | 864 | 14 |
| &nbsp;&nbsp;&nbsp; Head Office | 17 | 65 | (74) |
| **Total income** | **8163** | **7709** | **6** |
| Operating costs | (4359) | (4258) | (2) |
| UK regulatory levies | (84) | (96) | 13 |
| Litigation and conduct | (104) | (11) |  |
| **Total operating expenses** | **(4547)** | **(4365)** | **(4)** |
| Other net income | 21 | 18 | 17 |
| **Profit before impairment** | **3637** | **3362** | **8** |
| Credit impairment charges | (823) | (643) | (28) |
| **Profit before tax** | **2814** | **2719** | **3** |
| Tax charge | (638) | (621) | (3) |
| **Profit after tax** | **2176** | **2098** | **4** |
| Non-controlling interests | - | (2) |  |
| Other equity instrument holders | (244) | (232) | (5) |
| **Attributable profit** | **1932** | **1864** | **4** |
| **Performance measures**<br>|  |  |  |
| Return on average tangible shareholders' equity | 13.5% | 14.0% |  |
| Average tangible shareholders' equity (£bn) | 57.2 | 53.1 |  |
| Cost: income ratio | 56% | 57% |  |
| Loan loss rate (bps) | 74 | 61 |  |
| Basic earnings per ordinary share | 14.1p | 13.0p | 8 |
| Share buybacks announced (£m) | 500 | - |  |
| Total payout equivalent per share | c.3.6p | - |  |
| Basic weighted average number of shares (m) | 13727 | 14314 | (4) |
| Period end number of shares (m) | 13737 | 14336 | (4) |
| Period end tangible shareholders' equity (£bn) | 55.6 | 53.4 |  |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet and capital management<sup>1</sup>** | £bn | £bn | £bn |
| <br>Loans and advances at amortised cost | <br>438.6  | <br>430.0  | <br>419.4  |
| Loans and advances at amortised cost impairment coverage ratio | 1.3%  | 1.2%  | 1.2%  |
| Total assets | 1694.8  | 1544.2  | 1593.5  |
| Deposits at amortised cost | 587.6  | 585.6  | 574.3  |
| Tangible net asset value per share | 405p  | 409p  | 372p  |
| Common equity tier 1 ratio | 14.1%  | 14.3%  | 13.9%  |
| Common equity tier 1 capital | 51.2  | 51.1  | 48.8  |
| Risk weighted assets | 364.5  | 356.8  | 351.3  |
| UK leverage ratio | 4.8%  | 5.1%  | 5.0%  |
| UK leverage exposure | 1321.3  | 1247.3  | 1252.8  |
| **Funding and liquidity** |  |  |  |
| <br>Group liquidity pool (£bn) | <br> 326.1  | <br>337.8  | <br>336.3  |
| Liquidity coverage ratio<sup>2</sup> | 165.4%  | 170.0%  | 175.3%  |
| Net stable funding ratio<sup>3</sup> | 135.4%  | 135.2%  | 136.2%  |
| Loan: deposit ratio | 75%  | 73%  | 73%  |

---

---

| | |
|:---|:---|
| *1* | *Refer to pages 32 to 36 for further information on how capital, RWAs and leverage are calculated.* |
| *2* | *Represents average of the last 12 spot month end ratios. In June 2025, Barclays implemented a new methodology for calculating net stress outflows related to secured financing transactions in the liquidity coverage ratio (LCR).* |
| *3* | *Represents average of the last four spot quarter end positions.* |

---

 **Group Finance Director's Review**

 **Q126 Group performance**

- Group operating costs increased 2% to £4,359m, reflecting further investment spend, business growth and inflation, partially offset by c.£150m of cost efficiency savings and FX movements

- Litigation and conduct charges of £104m primarily reflected a £105m increase in the provision for the FCA motor finance redress scheme

 **Group capital and leverage**

- 53bps increase from attributable profit

- 41bps decrease driven by shareholder distributions including the £1.0bn share buyback announced with FY25 results and the accrual for the FY26 dividend

- 17bps decrease from other CET1 capital movements, including the net impact of share awards vesting

- 22bps decrease as a result of a £5.5bn increase in RWAs, excluding the impact of foreign exchange movements, primarily driven by lending growth in UK businesses and higher activity in Global Markets

- A £0.4bn increase in CET1 capital due to an increase in the currency translation reserve was partially offset by a £2.1bn increase in RWAs as a result of foreign exchange movements

 **Group funding and liquidity**

● The
liquidity metrics remain above regulatory requirements, underpinned
by well-diversified sources of funding, a stable global deposit
franchise and a highly liquid balance sheet

● The
liquidity pool was £326.1bn, a decrease of £11.7bn from
December 2025. The decrease in the liquidity pool was primarily
driven by increased utilisation across Markets and Investment
Banking and higher Treasury usage

● The average <sup>2</sup> LCR
was 165.4% (December 2025: 170.0%), equivalent to a surplus of
£125.9bn (December 2025: £131.2bn)

● Total
deposits increased to £587.6bn (December 2025: £585.6bn),
primarily driven by deposit growth in International Corporate Bank
in IB

● The average <sup>3</sup> Net
Stable Funding Ratio (NSFR) was 135.4% (December 2025: 135.2%),
which represents a £166.9bn surplus (December 2025:
£166.3bn) above the 100% regulatory
requirement

---

| | |
|:---|:---|
| *1*<br>| *Q126 includes c.£40m of fair value losses on lending. Q125 included c.£105m of fair value gains on leverage finance lending.*<br>|
| *2*<br>| *Represents average of the last 12 spot month end ratios. In June 2025, Barclays implemented a new methodology for calculating net stress outflows related to secured financing transactions in the liquidity coverage ratio.*<br>|
| *3*<br>| *Represents average of the last four spot quarter end ratios.*<br>|

---

 **Group funding and liquidity (continued)**

● Wholesale
funding outstanding, excluding repurchase agreements, was
£227.0bn (December 2025: £220.1bn)

● The
Group issued £3.0bn equivalent of minimum requirement for own
funds and eligible liabilities (MREL) instruments from Barclays PLC
(the Parent company) as of Q126. The Group has a strong MREL
position with a ratio of 35.4%, which is in excess of the
regulatory requirement of 30.5% excluding any applicable Prudential
Regulation Authority (PRA) buffer

 **Other matters**

**-** **American Airlines co-branded credit card portfolio exit**: On 24 April 2026 Barclays exited its American Airlines co-branded credit card partnership, releasing c.$5bn of RWAs and generating an estimated gain on sale of c.$300m

**-** **Best Egg, Inc. (Best Egg) acquisition:** On or around 1 May 2026, Barclays expects to complete the acquisition of Best Egg for $800m, subject to customary post-completion purchase price adjustments and satisfaction of remaining conditions to closing. Best Egg is a leading US direct-to-consumer personal loan origination platform focused on prime borrowers. The acquisition is expected to generate c.$500m of goodwill and intangibles

**-** The estimated net impact of both transactions is expected to marginally increase the Barclays Group CET1 ratio in Q226

 **Anna Cross, Group Finance Director**

 **Results by Business**

---

| | | | |
|:---|:---|:---|:---|
| **Barclays UK** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Income statement information** | £m | £m | % Change<br>|
| Net interest income | 1986 | 1822 | 9 |
| Net fee, commission and other income | 272 | 252 | 8 |
| **Total income** | **2258** | **2074** | **9** |
| Operating costs | (1174) | (1115) | (5) |
| UK regulatory levies | (44) | (43) | (2) |
| Litigation and conduct | 1 | (2) |  |
| **Total operating expenses** | **(1217)** | **(1160)** | **(5)** |
| Other net income<br>| - | - | - |
| **Profit before impairment** | **1041** | **914** | **14** |
| Credit impairment charges | (178) | (158) | (13) |
| **Profit before tax** | **863** | **756** | **14** |
| Attributable profit | 591 | 510 | 16 |
| **Performance measures** |  |  |  |
| Return on average allocated tangible equity | 19.7% | 17.4% |  |
| Average allocated tangible equity (£bn) | 12.0 | 11.7 |  |
| Cost: income ratio | 54% | 56% |  |
| Loan loss rate (bps) | 31 | 28 |  |
| Net interest margin | 3.72% | 3.55% |  |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet information** | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 217.8 | 216.5 | 209.6 |
| Total assets | 298.4 | 299.6 | 301.4 |
| Customer deposits at amortised cost | 243.9 | 244.6 | 243.1 |
| Loan: deposit ratio | 95% | 94% | 93% |
| Risk weighted assets | 87.5 | 85.8 | 85.0 |
| Period end allocated tangible equity | 12.0 | 11.8 | 11.8 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Analysis of Barclays UK** | **Three months ended** | **Three months ended** | **Three months ended** |
| **Analysis of Barclays UK** | **31.03.26** | **31.03.25** |  |
| **Analysis of total income** | £m | £m | % Change |
| Retail Banking | 1725 | 1573 | 10 |
| Business Banking | 533 | 501 | 6 |
| **Total income** | **2258** | **2074** | **9** |
| **Analysis of credit impairment (charges)/releases** |  |  |  |
| Retail Banking | (179) | (145) | (23) |
| Business Banking | 1 | (13) |  |
| **Total credit impairment charges** | **(178)** | **(158)** | **(13)** |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Analysis of loans and advances to customers at amortised cost** | £bn | £bn | £bn |
| Retail Banking | 200.1 | 198.6 | 190.4 |
| Business Banking | 17.7 | 17.9 | 19.2 |
| **Total loans and advances to customers at amortised cost** | **217.8** | **216.5** | **209.6** |
| **Analysis of customer deposits at amortised cost** |  |  |  |
| Retail Banking | 193.1 | 192.7 | 190.8 |
| Business Banking | 50.8 | 51.9 | 52.3 |
| **Total customer deposits at amortised cost** | **243.9** | **244.6** | **243.1** |

---

 **Barclays UK delivered a RoTE of 19.7% (Q125: 17.4%)** supported by robust income, disciplined cost management and underpinned by strong asset quality

 **Income statement - Q126 compared to Q125**

● **Profit before tax increased 14% to £863m** 

● **Total income increased 9% to £2,258m.** NII
increased 9% to £1,986m, as higher structural hedge income was
partially offset by retail deposit dynamics. Net fee, commission
and other income increased 8% to £272m

● **Total operating expenses increased 5% to £1,217m,** driven
by higher investments and inflation. Ongoing efficiency savings
continue to be reinvested, to drive sustainable improvement to the
cost: income ratio

● **Credit impairment charges were £178m (Q125: £158m),** reflecting
stable underlying credit performance, high quality mortgage lending
portfolio with a marginal increase in delinquencies in Retail
credit cards. A £10m adjustment has been recognised in the
Retail credit cards portfolio, reflecting a marginally weaker UK
unemployment baseline than assumed in the Q126 scenario. Retail
credit cards 30 and 90 day arrears rates were 0.9% (Q125: 0.7%) and
0.3% (Q125: 0.2%) respectively. The Retail credit cards total
coverage ratio was 4.6% (December 2025: 4.3%)

 **Balance sheet - 31 March 2026 compared to 31 December 2025**

● **Loans and advances to customers at amortised cost increased £1.3bn to £217.8bn**, primarily driven
by growth in mortgages

● **Customer deposits at amortised cost decreased by £0.7bn to £243.9bn,** driven
by seasonality. The loan: deposit ratio remained broadly stable at
95% (December 2025: 94%)

● **RWAs increased to £87.5bn (December 2025: £85.8bn),** primarily
due to growth in mortgages lending

---

| | | | |
|:---|:---|:---|:---|
| **Barclays UK Corporate Bank** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Income statement information** | £m | £m | % Change |
| Net interest income | 394 | 342 | 15 |
| Net fee, commission and other income | 136 | 142 | (4) |
| **Total income** | **530** | **484** | **10** |
| Operating costs | (239) | (234) | (2) |
| UK regulatory levies | (15) | (24) | 38 |
| Litigation and conduct | - | - |  |
| **Total operating expenses** | **(254)** | **(258)** | **2** |
| Other net income | - | - | - |
| **Profit before impairment** | **276** | **226** | **22** |
| Credit impairment charges | (3) | (19) | 84 |
| **Profit before tax** | **273** | **207** | **32** |
| Attributable profit | 187 | 142 | 32 |
| **Performance measures** |  |  |  |
| Return on average allocated tangible equity | 19.9% | 17.1% |  |
| Average allocated tangible equity (£bn) | 3.8 | 3.3 |  |
| Cost: income ratio | 48% | 53% |  |
| Loan loss rate (bps) | 4 | 28 |  |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet information** | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 30.8 | 30.0 | 26.7 |
| Deposits at amortised cost | 88.0 | 88.7 | 85.3 |
| Risk weighted assets | 27.3 | 26.5 | 24.2 |
| Period end allocated tangible equity | 3.7 | 3.7 | 3.4 |
|  | **31.03.26** | **31.03.25** |  |
| **Analysis of total income** | £m | £m | % Change |
| Corporate lending | 89 | 80 | 11 |
| Transaction banking | 441 | 404 | 9 |
| **Total income** | **530** | **484** | **10** |

---

 **UKCB delivered a RoTE of 19.9% (Q125: 17.1%)**, as increased income from higher average deposit and lending balances, and positive operating jaws were partially offset by higher RWAs to support future growth ambitions.

 **Income statement - Q126 compared to Q125**

● **Profit before tax increased 32% to £273m** 

● **Total income increased 10% to £530m,** NII
increased 15% to £394m, driven by higher average deposit and
lending balances, and structural hedge income benefit. Net fee,
commission, trading and other income was broadly stable at
£136m

● **Total operating expenses decreased 2% to £254m,** reflecting
a reduction in UK regulatory levies to £15m (Q125: £24m).
Operating costs increased 2% to £239m, reflecting higher
investment spend to support business growth ambitions, with ongoing
efficiency savings offsetting inflationary
headwinds

● **Credit impairment charges were £3m (Q125: £19m)**,
reflecting strong underlying credit performance and limited single
name charges

 **Balance sheet - 31 March 2026 compared to 31 December 2025**

● **Loans and advances to customers at amortised cost increased to £30.8bn (December 2025: £30.0bn),** reflecting
the strategic focus to grow lending

● **Deposits at amortised cost of £88.0bn (December 2025: £88.7bn)** were
broadly stable

● **RWAs increased to £27.3bn (December 2025: £26.5bn)**,
reflecting higher client lending limits and growth in lending
balances

---

| | | | |
|:---|:---|:---|:---|
| **Barclays Private Bank and Wealth Management** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Income statement information** | £m | £m | % Change |
| Net interest income | 204 | 204 | - |
| Net fee, commission and other income | 143 | 145 | (1) |
| **Total income** | **347** | **349** | **(1)** |
| Operating costs | (254) | (234) | (9) |
| UK regulatory levies | (3) | (2) | (50) |
| Litigation and conduct | - | - |  |
| **Total operating expenses** | **(257)** | **(236)** | **(9)** |
| Other net income | - | - | - |
| **Profit before impairment** | **90** | **113** | **(20)** |
| Credit impairment releases | 2 | 9 | (78) |
| **Profit before tax** | **92** | **122** | **(25)** |
| Attributable profit | 73 | 96 | (24) |
| **Performance measures** |  |  |  |
| Return on average allocated tangible equity | 25.5% | 34.5% |  |
| Average allocated tangible equity (£bn) | 1.1 | 1.1 |  |
| Cost: income ratio | 74% | 68% |  |
| Loan loss rate (bps) | (6) | (25) |  |
| **Key facts** | £bn | £bn |  |
| Net new assets under management<sup>1</sup> | 1.5 | 1.0 |  |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet information** | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 14.7 | 14.7 | 14.5 |
| Deposits at amortised cost | 73.3 | 72.0 | 73.1 |
| Risk weighted assets | 8.2 | 8.0 | 8.0 |
| Period end allocated tangible equity | 1.1 | 1.1 | 1.1 |
| Invested assets<sup>2</sup> | 135.4 | 140.6 | 124.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Of which:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Assets under management<sup>1</sup>* | 51.6 | 52.9 | 47.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Assets under supervision<sup>1</sup>* | 83.8 | 87.7 | 76.6 |
| Client assets and liabilities<sup>3</sup> | 223.8 | 227.6 | 212.4 |

---

 **PBWM delivered a RoTE of 25.5% (Q125: 34.5%**), reflecting higher costs from accelerated investment to support future growth and efficiency ambitions, and a lower credit impairment release.

 **Income statement - Q126 compared to Q125**

● **Profit before tax decreased 25% to £92m** 

● **Total income was broadly stable at £347m,** as
growth from higher client balances was offset by the impact of
deposit mix

● **Total operating expenses increased 9% to £257m,** reflecting
ongoing investment to support business growth ambitions and
inflationary headwinds, partially offset by efficiency
savings

 **Balance sheet - 31 March 2026 compared to 31 December 2025**

● **Client assets and liabilities decreased £3.8bn to £223.8bn**, driven by the impact of negative market
movements on invested assets, partially offset by net new inflows
and FX impacts

● **RWAs were broadly stable at £8.2bn (December 2025: £8.0bn)** 

---

| | |
|:---|:---|
| *1*<br>| *Refer to page 40 for further information on net new assets under management, assets under management and assets under supervision.*<br>|
| *2*<br>| *Invested assets (held off-balance sheet) represent assets under management and supervision. Uninvested cash held under an investment mandate and reported within deposits is excluded from invested assets.*<br>|
| *3*<br>| *Client assets and liabilities refers to deposits, lending and invested assets.*<br>|

---

---

| | | | |
|:---|:---|:---|:---|
| **Barclays Investment Bank** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Income statement information** | £m | £m | % Change |
| Net interest income | 383 | 297 | 29 |
| Net trading income | 2358 | 2416 | (2) |
| Net fee, commission and other income | 1287 | 1160 | 11 |
| **Total income** | **4028** | **3873** | **4** |
| Operating costs | (2107) | (2061) | (2) |
| UK regulatory levies | (22) | (27) | 19 |
| Litigation and conduct | 2 | (3) |  |
| **Total operating expenses** | **(2127)** | **(2091)** | **(2)** |
| Other net income<br>| - | - | - |
| **Profit before impairment** | **1901** | **1782** | **7** |
| Credit impairment charges<br>| (279) | (72) |  |
| **Profit before tax** | **1622** | **1710** | **(5)** |
| Attributable profit | 1111 | 1199 | (7) |
| **Performance measures** |  |  |  |
| Return on average allocated tangible equity | 15.0% | 16.2% |  |
| Average allocated tangible equity (£bn) | 29.7 | 29.6 |  |
| Income over average risk weighted assets | 8.0% | 7.7% |  |
| Cost: income ratio | 53% | 54% |  |
| Loan loss rate (bps) | 82 | 23 |  |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet information** | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 73.6 | 70.0 | 68.6 |
| Loans and advances to banks at amortised cost | 10.0 | 7.4 | 7.4 |
| Debt securities at amortised cost | 52.9 | 52.9 | 53.1 |
| **Loans and advances at amortised cost** | **136.5** | **130.3** | **129.1** |
| Trading portfolio assets | 189.3 | 189.5 | 185.5 |
| Derivative financial instrument assets | 285.4 | 251.5 | 253.6 |
| Financial assets at fair value through the income statement | 215.6 | 183.6 | 209.5 |
| Cash collateral and settlement balances | 189.2 | 121.6 | 148.8 |
| Deposits at amortised cost | 157.4 | 156.1 | 148.9 |
| Derivative financial instrument liabilities | 272.6 | 240.6 | 245.1 |
| Risk weighted assets | 201.7 | 196.7 | 195.9 |
| Period end allocated tangible equity | 29.6 | 28.9 | 28.9 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Analysis of total income** | £m | £m | % Change |
| &nbsp;&nbsp;&nbsp; FICC | 1716 | 1699 | 1 |
| &nbsp;&nbsp;&nbsp; Equities | 1116 | 963 | 16 |
| **Global Markets** | **2832** | **2662** | **6** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Advisory | 255 | 143 | 78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity capital markets | 92 | 70 | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Debt capital markets | 407 | 431 | (6) |
| &nbsp;&nbsp;&nbsp; Banking fees and underwriting | 754 | 644 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate lending<sup>1</sup> | 16 | 156 | (90) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transaction banking | 426 | 411 | 4 |
| &nbsp;&nbsp;&nbsp; International Corporate Bank | 442 | 567 | (22) |
| **Investment Banking** | **1196** | **1211** | **(1)** |
| **Total income** | **4028** | **3873** | **4** |

---

---

| | |
|:---|:---|
| *1*<br>| *Q126 includes c.£40m of fair value losses on lending. Q125 included c.£105m of fair value gains on leverage finance lending.* |

---

 **IB delivered a RoTE of 15.0% (Q125: 16.2%**), driven by Global Markets and Investment Banking fees and underwriting income, whilst maintaining cost and capital discipline, driving positive operating jaws and improved RWA productivity.

 **Income statement - Q126 compared to Q125**

- Global Markets income increased 6% to £2,832m, driven by increased income in Equities and Credit

- Investment Banking income was broadly stable at £1,196m (Q125: £1,211m)

 **Balance sheet - 31 March 2026 compared to 31 December 2025**

● **Loans and advances at amortised cost increased to £136.5bn (December 2025: £130.3bn),** driven
by increased lending across Global Markets and
Banking

● **Cash collateral and settlement balances increased to £189.2bn (December 2025: £121.6bn),** primarily
driven by seasonality and higher client activity during a period of
elevated volatility

● **Financial assets at fair value through the income statement increased to £215.6bn (December 2025: £183.6bn),** driven
by an increase in activity as we continue to support clients
through a range of environments

● **Derivative financial instrument assets increased to £285.4bn (December 2025: £251.5bn) and liabilities increased to £272.6bn (December 2025: £240.6bn),** primarily
driven by the strengthening of spot USD against GBP in Q126 and
elevated volatility

● **RWAs increased to £201.7bn (December 2025: £196.7bn),** mainly
driven by higher activity in Global Markets as we continued to
support clients through a range of environments

---

| | |
|:---|:---|
| *1*<br>| *Q126 includes c.£40m of fair value losses on lending. Q125 included c.£105m of fair value gains on leverage finance lending.* |
| *2*<br>| *Net of Significant Risk Transfer (SRT).* |

---

---

| | | | |
|:---|:---|:---|:---|
| **Barclays US Consumer Bank** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Income statement information** | £m | £m | % Change |
| Net interest income | 823 | 678 | 21 |
| Net fee, commission and other income | 160 | 186 | (14) |
| **Total income** | **983** | **864** | **14** |
| Operating costs | (380) | (407) | 7 |
| UK regulatory levies | - | - |  |
| Litigation and conduct | - | (3) |  |
| **Total operating expenses** | **(380)** | **(410)** | **7** |
| Other net income | - | - |  |
| **Profit before impairment** | **603** | **454** | **33** |
| Credit impairment charges<br>| (367) | (399) | 8 |
| **Profit before tax** | **236** | **55** |  |
| Attributable profit | 176 | 41 |  |
| **Performance measures** |  |  |  |
| Return on average allocated tangible equity | 18.8% | 4.5% |  |
| Average allocated tangible equity (£bn) | 3.8 | 3.6 |  |
| Cost: income ratio | 39% | 47% |  |
| Loan loss rate (bps) | 491 | 562 |  |
| Net interest margin | 12.76% | 10.53% |  |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet information** | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 21.0 | 21.1 | 18.8 |
| Deposits at amortised cost | 25.0 | 24.2 | 23.8 |
| Risk weighted assets | 27.6 | 27.4 | 25.6 |
| Period end allocated tangible equity | 3.8 | 3.8 | 3.5 |

---

 **USCB delivered a RoTE of 18.8% (Q125: 4.5%)**, reflecting continued operational progress, with increased income from business growth and higher net interest margin, positive operating jaws, and lower credit impairment charges.

 **Income statement - Q126 compared to Q125**

● **Profit before tax increased to £236m (Q125: £55m)** 

● The
7% appreciation of average GBP against USD adversely impacted
income and profits, and positively impacted credit impairment
charges and total operating expenses

● **Total income increased 14% to £983m,** driven
by organic business growth, the acquisition of the General Motors
co-branded cards portfolio (GM portfolio) and increased purchase
activity, partially offset by the strengthening of average GBP
against USD. NII increased 21% to £823m with a net interest
margin (NIM) of 12.76% (Q125: 10.53%), including business growth
and repricing initiatives. Net fee, commission and other income
decreased 14% to £160m driven by the Q425 partner reward
updates, partially offset by purchases and fee
growth

● **Total operating expenses decreased 7% to £380m,** reflecting
the strengthening of average GBP against USD, as business growth
and inflationary headwinds were broadly offset by lower partner
related expenses and ongoing efficiency savings

● **Credit impairment charges decreased to £367m (Q125: £399m**), reflecting stable underlying credit
performance. The tariff related management adjustment from Q125 of
£36m was released, due to the lack of tariff-driven credit
deterioration and losses. However, geopolitical uncertainty
persists and is reflected through holding back a £29m release
arising from the Q126 macroeconomic scenario. US cards 30 and 90
day arrears rates <sup>1</sup> were
3.1% (Q125: 3.0%) and 1.7% (Q125: 1.6%) respectively. The USCB
total coverage ratio was 11.5% (December 2025:
11.1%)

 **Balance sheet - 31 March 2026 compared to 31 December 2025**

● **Loans and advances to customers at amortised cost were broadly stable at £21.0bn (December 2025: £21.1bn)** 

● **Deposits at amortised cost increased to £25.0bn (December 2025: £24.2bn)**, with growth in
retail savings which is in line with USCB's ambition to grow core
deposits

● **RWAs were broadly stable at £27.6bn (December 2025: £27.4bn)** 

 *1* *Including a co-branded cards portfolio classified as assets held for sale.*

---

| | | | |
|:---|:---|:---|:---|
| **Head Office** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **31.03.26** | **31.03.25** |  |
| **Income statement information** | £m | £m | % Change |
| Net interest income | (53) | 174 |  |
| Net fee, commission and other income | 70 | (109) |  |
| **Total income** | **17** | **65** | **(74)** |
| Operating costs | (205) | (207) | 1 |
| UK regulatory levies | - | - |  |
| Litigation and conduct | (107) | (3) |  |
| **Total operating expenses** | **(312)** | **(210)** | **(49)** |
| Other net income<br>| 21 | 18 | 17 |
| **Loss before impairment** | **(274)** | **(127)** |  |
| Credit impairment releases/(charges)<br>| 2 | (4) |  |
| **Loss before tax** | **(272)** | **(131)** |  |
| Attributable loss | (206) | (124) | (66) |
| **Performance measures** |  |  |  |
| Average allocated tangible equity (£bn) | 6.8 | 3.8 |  |
|  | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
| **Balance sheet information** | £bn | £bn | £bn |
| Risk weighted assets | 12.3 | 12.3 | 12.7 |
| Period end allocated tangible equity | 5.4 | 7.5 | 4.7 |

---

 **Income statement - Q126 compared to Q125**

● **Loss before tax was £272m (Q125: £131m)** 

● **Total income decreased to £17m (Q125: £65m),** driven
by the impact of the disposal of the German consumer finance
business in Q125, and mark-to-market losses on legacy
investments

● **Total operating expenses increased to £312m (Q125: £210m),** reflecting
a £105m increase in the provision for the FCA motor finance
redress scheme

 **Balance sheet - 31 March 2026 compared to 31 December 2025**

● **RWAs were stable at £12.3bn (December 2025: £12.3bn)** 

 **Quarterly Results Summary**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Group**<br>|  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 3737 | 3734 | 3745 | 3505 | 3517 | 3500 | 3308 | 3056 |
| Net fee, commission and other income | 4426 | 3343 | 3422 | 3682 | 4192 | 3464 | 3239 | 3268 |
| **Total income** | **8163** | **7077** | **7167** | **7187** | **7709** | **6964** | **6547** | **6324** |
| Operating costs | (4359) | (4379) | (4254) | (4149) | (4258) | (4244) | (3954) | (3999) |
| UK regulatory levies | (84) | (229) | 12 | - | (96) | (227) | 27 | - |
| Litigation and conduct | (104) | (50) | (255) | (76) | (11) | (121) | (35) | (7) |
| **Total operating expenses** | **(4547)** | **(4658)** | **(4497)** | **(4225)** | **(4365)** | **(4592)** | **(3962)** | **(4006)** |
| Other net income/(expenses) | 21 | (25) | 39 | (9) | 18 | - | 21 | 4 |
| **Profit before impairment** | **3637** | **2394** | **2709** | **2953** | **3362** | **2372** | **2606** | **2322** |
| Credit impairment charges | (823) | (535) | (632) | (469) | (643) | (711) | (374) | (384) |
| **Profit before tax** | **2814** | **1859** | **2077** | **2484** | **2719** | **1661** | **2232** | **1938** |
| Tax charges | (638) | (388) | (365) | (552) | (621) | (448) | (412) | (427) |
| **Profit after tax** | **2176** | **1471** | **1712** | **1932** | **2098** | **1213** | **1820** | **1511** |
| Non-controlling interests | - | (18) | - | (21) | (2) | (20) | (3) | (23) |
| Other equity instrument holders | (244) | (258) | (255) | (252) | (232) | (228) | (253) | (251) |
| **Attributable profit** | **1932** | **1195** | **1457** | **1659** | **1864** | **965** | **1564** | **1237** |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average tangible shareholders' equity | 13.5% | 8.5% | 10.6% | 12.3% | 14.0% | 7.5% | 12.3% | 9.9% |
| Average tangible shareholders' equity (£bn) | 57.2 | 56.5 | 55.1 | 53.9 | 53.1 | 51.5 | 51.0 | 49.8 |
| Cost: income ratio | 56% | 66% | 63% | 59% | 57% | 66% | 61% | 63% |
| Loan loss rate (bps) | 74 | 48 | 57 | 44 | 61 | 66 | 37 | 38 |
| Basic earnings per ordinary share | 14.1p | 8.6p | 10.4p | 11.7p | 13.0p | 6.7p | 10.7p | 8.3p |
| Basic weighted average number of shares (m) | 13727 | 13883 | 14045 | 14211 | 14314 | 14432 | 14648 | 14915 |
| Period end number of shares (m) | 13737 | 13867 | 13996 | 14180 | 14336 | 14420 | 14571 | 14826 |
| Period end tangible shareholders' equity (£bn) | 55.6 | 56.8 | 54.9 | 54.5 | 53.4 | 51.5 | 51.1 | 50.4 |
| **Balance sheet and capital management<sup>1</sup>** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 358.3 | 352.8 | 346.4 | 339.2 | 338.6 | 337.9 | 326.5 | 329.8 |
| Loans and advances to banks at amortised cost | 12.0 | 8.7 | 9.4 | 8.7 | 9.4 | 8.3 | 8.1 | 8.0 |
| Debt securities at amortised cost | 68.3 | 68.5 | 70.7 | 69.9 | 71.4 | 68.2 | 64.6 | 61.7 |
| **Loans and advances at amortised cost** | **438.6** | **430.0** | **426.5** | **417.8** | **419.4** | **414.5** | **399.2** | **399.5** |
| Loans and advances at amortised cost impairment coverage ratio | 1.3% | 1.2% | 1.2% | 1.2% | 1.2% | 1.2% | 1.3% | 1.4% |
| Total assets | 1694.8 | 1544.2 | 1629.2 | 1598.7 | 1593.5 | 1518.2 | 1531.1 | 1576.6 |
| Deposits at amortised cost | 587.6 | 585.6 | 575.3 | 564.5 | 574.3 | 560.7 | 542.8 | 557.5 |
| Tangible net asset value per share | 405p | 409p | 392p | 384p | 372p | 357p | 351p | 340p |
| Common equity tier 1 ratio | 14.1% | 14.3% | 14.1% | 14.0% | 13.9% | 13.6% | 13.8% | 13.6% |
| Common equity tier 1 capital | 51.2 | 51.1 | 50.3 | 49.5 | 48.8 | 48.6 | 47.0 | 47.7 |
| Risk weighted assets | 364.5 | 356.8 | 357.4 | 353.0 | 351.3 | 358.1 | 340.4 | 351.4 |
| UK leverage ratio | 4.8% | 5.1% | 4.9% | 5.0% | 5.0% | 5.0% | 4.9% | 5.0% |
| UK leverage exposure | 1321.3 | 1247.3 | 1285.3 | 1259.8 | 1252.8 | 1206.5 | 1197.4 | 1222.7 |
| **Funding and liquidity** |  |  |  |  |  |  |  |  |
| Group liquidity pool (£bn) | 326.1 | 337.8 | 332.9 | 333.7 | 336.3 | 296.9 | 311.7 | 328.7 |
| Liquidity coverage ratio | 165.4% | 170.0% | 174.6% | 177.7% | 175.3% | 172.4% | 170.1% | 167.0% |
| Net stable funding ratio | 135.4% | 135.2% | 135.3% | 135.6% | 136.2% | 134.9% | 135.6% | 136.4% |
| Loan: deposit ratio | 75% | 73% | 74% | 74% | 73% | 74% | 74% | 72% |

---

 *1* *Refer to pages 32 to 36 for further information on how capital, RWAs and leverage are calculated.*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK** |  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424<sup>1</sup>** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 1986 | 2015 | 1961 | 1855 | 1822 | 1815 | 1666 | 1597 |
| Net fee, commission and other income | 272 | 247 | 292 | 264 | 252 | 800 | 280 | 290 |
| **Total income** | **2258** | **2262** | **2253** | **2119** | **2074** | **2615** | **1946** | **1887** |
| Operating costs | (1174) | (1274) | (1189) | (1168) | (1115) | (1170) | (1017) | (1041) |
| UK regulatory levies | (44) | (41) | (1) | - | (43) | (36) | 12 | - |
| Litigation and conduct | 1 | (14) | (8) | (27) | (2) | (9) | (1) | (4) |
| **Total operating expenses** | **(1217)** | **(1329)** | **(1198)** | **(1195)** | **(1160)** | **(1215)** | **(1006)** | **(1045)** |
| Other net income | - | - | - | - | - | - | - | - |
| **Profit before impairment** | **1041** | **933** | **1055** | **924** | **914** | **1400** | **940** | **842** |
| Credit impairment charges | (178) | (74) | (102) | (79) | (158) | (283) | (16) | (8) |
| **Profit before tax** | **863** | **859** | **953** | **845** | **756** | **1117** | **924** | **834** |
| Attributable profit | 591 | 706 | 647 | 580 | 510 | 781 | 621 | 584 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 217.8 | 216.5 | 213.4 | 211.2 | 209.6 | 207.7 | 199.3 | 198.7 |
| Customer deposits at amortised cost | 243.9 | 244.6 | 241.5 | 241.3 | 243.1 | 244.2 | 236.3 | 236.8 |
| Loan: deposit ratio | 95% | 94% | 95% | 94% | 93% | 92% | 92% | 91% |
| Risk weighted assets | 87.5 | 85.8 | 86.7 | 86.1 | 85.0 | 84.5 | 77.5 | 76.5 |
| Period end allocated tangible equity | 12.0 | 11.8 | 11.9 | 11.8 | 11.8 | 11.6 | 10.7 | 10.6 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 19.7% | 23.8% | 21.8% | 19.7% | 17.4% | 28.0% | 23.4% | 22.3% |
| Average allocated tangible equity (£bn) | 12.0 | 11.9 | 11.9 | 11.8 | 11.7 | 11.2 | 10.6 | 10.5 |
| Cost: income ratio | 54% | 59% | 53% | 56% | 56% | 46% | 52% | 55% |
| Loan loss rate (bps) | 31 | 13 | 18 | 14 | 28 | 49 | 3 | 1 |
| Net interest margin | 3.72% | 3.72% | 3.68% | 3.55% | 3.55% | 3.53% | 3.34% | 3.22% |

---

---

| | |
|:---|:---|
| *1* | *Q424 includes the day 1 impacts from the acquisition of Tesco Bank: total Income includes a £556m gain, and credit impairment charges includes a £209m charge.*<br>|

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Analysis of Barclays UK** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424<sup>1</sup>** | **Q324** | **Q224** |
| **Analysis of total income** | £m | £m | £m | £m | £m | £m | £m | £m |
| Retail Banking | 1725 | 1702 | 1708 | 1599 | 1573 | 2078 | 1433 | 1402 |
| Business Banking | 533 | 560 | 545 | 520 | 501 | 537 | 513 | 485 |
| **Total income** | **2258** | **2262** | **2253** | **2119** | **2074** | **2615** | **1946** | **1887** |
| **Analysis of credit impairment (charges)/releases** |  |  |  |  |  |  |  |  |
| Retail Banking | (179) | (72) | (98) | (59) | (145) | (279) | (12) | (51) |
| Business Banking | 1 | (2) | (4) | (20) | (13) | (4) | (4) | 43 |
| **Total credit impairment charges** | **(178)** | **(74)** | **(102)** | **(79)** | **(158)** | **(283)** | **(16)** | **(8)** |
| **Analysis of loans and advances to customers at amortised cost** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Retail Banking | 200.1 | 198.6 | 195.2 | 192.4 | 190.4 | 188.0 | 178.7 | 177.5 |
| Business Banking | 17.7 | 17.9 | 18.2 | 18.8 | 19.2 | 19.7 | 20.6 | 21.2 |
| **Total loans and advances to customers at amortised cost** | **217.8** | **216.5** | **213.4** | **211.2** | **209.6** | **207.7** | **199.3** | **198.7** |
| **Analysis of customer deposits at amortised cost** |  |  |  |  |  |  |  |  |
| Retail Banking | 193.1 | 192.7 | 189.3 | 189.3 | 190.8 | 191.4 | 182.9 | 183.3 |
| Business Banking | 50.8 | 51.9 | 52.2 | 52.0 | 52.3 | 52.8 | 53.4 | 53.5 |
| **Total customer deposits at amortised cost** | **243.9** | **244.6** | **241.5** | **241.3** | **243.1** | **244.2** | **236.3** | **236.8** |

---

---

| | |
|:---|:---|
| *1* | *Q424 includes the day 1 impacts from the acquisition of Tesco Bank: total Income includes a £556m gain, and credit impairment charges includes a £209m charge.*<br>|

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK Corporate Bank** |  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 394 | 396 | 383 | 359 | 342 | 324 | 309 | 296 |
| Net fee, commission, trading and other income | 136 | 143 | 139 | 160 | 142 | 134 | 136 | 147 |
| **Total income** | **530** | **539** | **522** | **519** | **484** | **458** | **445** | **443** |
| Operating costs | (239) | (272) | (243) | (240) | (234) | (250) | (229) | (235) |
| UK regulatory levies | (15) | (14) | 9 | - | (24) | (14) | 7 | - |
| Litigation and conduct | - | - | - | (39) | - | (1) | - | - |
| **Total operating expenses** | **(254)** | **(286)** | **(234)** | **(279)** | **(258)** | **(265)** | **(222)** | **(235)** |
| Other net income | - | - | - | - | - | - | - | - |
| **Profit before impairment** | **276** | **253** | **288** | **240** | **226** | **193** | **223** | **208** |
| Credit impairment charges | (3) | (1) | (5) | (12) | (19) | (40) | (13) | (8) |
| **Profit before tax** | **273** | **252** | **283** | **228** | **207** | **153** | **210** | **200** |
| Attributable profit | 187 | 168 | 196 | 142 | 142 | 98 | 144 | 135 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 30.8 | 30.0 | 29.0 | 27.9 | 26.7 | 25.4 | 24.8 | 25.7 |
| Deposits at amortised cost | 88.0 | 88.7 | 86.7 | 85.3 | 85.3 | 83.1 | 82.3 | 84.9 |
| Risk weighted assets | 27.3 | 26.5 | 25.2 | 25.3 | 24.2 | 23.9 | 22.1 | 21.9 |
| Period end allocated tangible equity | 3.7 | 3.7 | 3.4 | 3.5 | 3.4 | 3.3 | 3.0 | 3.0 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 19.9% | 19.1% | 22.8% | 16.6% | 17.1% | 12.3% | 18.8% | 18.0% |
| Average allocated tangible equity (£bn) | 3.8 | 3.5 | 3.4 | 3.4 | 3.3 | 3.2 | 3.1 | 3.0 |
| Cost: income ratio | 48% | 53% | 45% | 54% | 53% | 58% | 50% | 53% |
| Loan loss rate (bps) | 4 | 1 | 7 | 17 | 28 | 62 | 21 | 12 |
| **Analysis of total income** | £m | £m | £m | £m | £m | £m | £m | £m |
| Corporate lending | 89 | 97 | 90 | 90 | 80 | 71 | 67 | 57 |
| Transaction banking | 441 | 442 | 432 | 429 | 404 | 387 | 378 | 386 |
| **Total income** | **530** | **539** | **522** | **519** | **484** | **458** | **445** | **443** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Private Bank and Wealth Management** |  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 204 | 202 | 190 | 203 | 204 | 216 | 189 | 187 |
| Net fee, commission and other income | 143 | 146 | 145 | 145 | 145 | 135 | 137 | 133 |
| **Total income** | **347** | **348** | **335** | **348** | **349** | **351** | **326** | **320** |
| Operating costs | (254) | (279) | (243) | (238) | (234) | (255) | (222) | (220) |
| UK regulatory levies | (3) | (7) | (1) | - | (2) | (7) | 1 | - |
| Litigation and conduct | - | (10) | 1 | - | - | (1) | - | 1 |
| **Total operating expenses** | **(257)** | **(296)** | **(243)** | **(238)** | **(236)** | **(263)** | **(221)** | **(219)** |
| Other net income | - | - | - | - | - | - | - | - |
| **Profit before impairment** | **90** | **52** | **92** | **110** | **113** | **88** | **105** | **101** |
| Credit impairment releases/(charges) | 2 | (2) | (1) | 2 | 9 | (2) | (7) | 3 |
| **Profit before tax** | **92** | **50** | **91** | **112** | **122** | **86** | **98** | **104** |
| Attributable profit | 73 | 35 | 72 | 88 | 96 | 63 | 74 | 77 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 14.7 | 14.7 | 14.9 | 14.5 | 14.5 | 14.5 | 14.0 | 13.9 |
| Deposits at amortised cost | 73.3 | 72.0 | 70.6 | 66.7 | 73.1 | 69.5 | 64.8 | 64.6 |
| Risk weighted assets | 8.2 | 8.0 | 7.9 | 7.9 | 8.0 | 7.9 | 7.3 | 7.0 |
| Period end allocated tangible equity | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 1.0 |
| Client assets and liabilities<sup>1</sup> | 223.8 | 227.6 | 221.5 | 213.4 | 212.4 | 208.9 | 201.5 | 198.5 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 25.5% | 12.6% | 26.4% | 31.9% | 34.5% | 23.9% | 29.0% | 30.8% |
| Average allocated tangible equity (£bn) | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 1.0 |
| Cost: income ratio | 74% | 85% | 73% | 68% | 68% | 75% | 68% | 68% |
| Loan loss rate (bps) | (6) | 5 | 3 | (5) | (25) | 5 | 19 | (9) |

---

 *1* *Client assets and liabilities refers to deposits, lending and invested assets.*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Investment Bank** |  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 383 | 356 | 347 | 334 | 297 | 284 | 282 | 268 |
| Net trading income | 2358 | 1294 | 1581 | 1906 | 2416 | 1262 | 1512 | 1485 |
| Net fee, commission and other income | 1287 | 1142 | 1155 | 1067 | 1160 | 1061 | 1057 | 1266 |
| **Total income** | **4028** | **2792** | **3083** | **3307** | **3873** | **2607** | **2851** | **3019** |
| Operating costs | (2107) | (1924) | (2010) | (1932) | (2061) | (1903) | (1906) | (1900) |
| UK regulatory levies | (22) | (159) | 5 | - | (27) | (161) | 7 | - |
| Litigation and conduct | 2 | (8) | (9) | (8) | (3) | (26) | (17) | (3) |
| **Total operating expenses** | **(2127)** | **(2091)** | **(2014)** | **(1940)** | **(2091)** | **(2090)** | **(1916)** | **(1903)** |
| Other net income | - | - | - | - | - | - | - | - |
| **Profit before impairment** | **1901** | **701** | **1069** | **1367** | **1782** | **517** | **935** | **1116** |
| Credit impairment charges | (279) | (22) | (144) | (67) | (72) | (46) | (43) | (44) |
| **Profit before tax** | **1622** | **679** | **925** | **1300** | **1710** | **471** | **892** | **1072** |
| Attributable profit | 1111 | 294 | 723 | 876 | 1199 | 247 | 652 | 715 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 73.6 | 70.0 | 68.6 | 66.8 | 68.6 | 69.7 | 64.5 | 66.6 |
| Loans and advances to banks at amortised cost | 10.0 | 7.4 | 7.5 | 7.1 | 7.4 | 6.8 | 6.7 | 6.6 |
| Debt securities at amortised cost | 52.9 | 52.9 | 53.0 | 52.4 | 53.1 | 47.9 | 44.8 | 41.7 |
| **Loans and advances at amortised cost** | **136.5** | **130.3** | **129.1** | **126.3** | **129.1** | **124.4** | **116.0** | **114.9** |
| Trading portfolio assets | 189.3 | 189.5 | 191.3 | 186.1 | 185.5 | 166.1 | 185.8 | 197.2 |
| Derivative financial instrument assets | 285.4 | 251.5 | 263.8 | 279.0 | 253.6 | 291.6 | 256.7 | 251.4 |
| Financial assets at fair value through the income statement | 215.6 | 183.6 | 222.8 | 215.2 | 209.5 | 190.4 | 210.8 | 211.7 |
| Cash collateral and settlement balances | 189.2 | 121.6 | 152.1 | 145.0 | 148.8 | 111.1 | 134.7 | 139.8 |
| Deposits at amortised cost | 157.4 | 156.1 | 152.8 | 148.7 | 148.9 | 140.5 | 139.8 | 151.3 |
| Derivative financial instrument liabilities | 272.6 | 240.6 | 252.0 | 265.1 | 245.1 | 279.0 | 249.4 | 241.8 |
| Risk weighted assets | 201.7 | 196.7 | 199.1 | 196.4 | 195.9 | 198.8 | 194.2 | 203.3 |
| Period end allocated tangible equity | 29.6 | 28.9 | 29.1 | 28.7 | 28.9 | 29.3 | 28.4 | 29.7 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 15.0% | 4.0% | 10.1% | 12.2% | 16.2% | 3.4% | 8.8% | 9.6% |
| Average allocated tangible equity (£bn) | 29.7 | 29.6 | 28.6 | 28.7 | 29.6 | 29.3 | 29.5 | 29.9 |
| Income over average risk weighted assets | 8.0% | 5.5% | 6.3% | 6.7% | 7.7% | 5.2% | 5.7% | 5.9% |
| Cost: income ratio | 53% | 75% | 65% | 59% | 54% | 80% | 67% | 63% |
| Loan loss rate (bps) | 82 | 7 | 44 | 21 | 23 | 15 | 15 | 15 |
| **Analysis of total income** | £m | £m | £m | £m | £m | £m | £m | £m |
| &nbsp;&nbsp;&nbsp; FICC | 1716 | 1024 | 1256 | 1450 | 1699 | 934 | 1180 | 1149 |
| &nbsp;&nbsp;&nbsp; Equities | 1116 | 703 | 689 | 870 | 963 | 604 | 692 | 696 |
| **Global Markets** | **2832** | **1727** | **1945** | **2320** | **2662** | **1538** | **1872** | **1845** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Advisory | 255 | 214 | 196 | 123 | 143 | 189 | 186 | 138 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity capital markets | 92 | 56 | 71 | 81 | 70 | 98 | 64 | 121 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Debt capital markets | 407 | 336 | 379 | 364 | 431 | 327 | 344 | 420 |
| &nbsp;&nbsp;&nbsp; Banking Fees and Underwriting | 754 | 606 | 646 | 568 | 644 | 614 | 594 | 679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate lending | 16 | 27 | 68 | (4) | 156 | 45 | (21) | 87 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transaction banking | 426 | 432 | 424 | 423 | 411 | 410 | 406 | 408 |
| &nbsp;&nbsp;&nbsp; International Corporate Banking | 442 | 459 | 492 | 419 | 567 | 455 | 385 | 495 |
| **Investment Banking** | **1196** | **1065** | **1138** | **987** | **1211** | **1069** | **979** | **1174** |
| **Total income** | **4028** | **2792** | **3083** | **3307** | **3873** | **2607** | **2851** | **3019** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays US Consumer Bank** |  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | 823 | 776 | 726 | 640 | 678 | 678 | 647 | 646 |
| Net fee, commission, trading and other income | 160 | 277 | 215 | 183 | 186 | 179 | 144 | 173 |
| **Total income** | **983** | **1053** | **941** | **823** | **864** | **857** | **791** | **819** |
| Operating costs | (380) | (427) | (407) | (396) | (407) | (433) | (384) | (408) |
| UK regulatory levies | - | - | - | - | - | - | - | - |
| Litigation and conduct | - | (5) | - | - | (3) | - | (9) | (2) |
| **Total operating expenses** | **(380)** | **(432)** | **(407)** | **(396)** | **(410)** | **(433)** | **(393)** | **(410)** |
| Other net income | - | - | - | - | - | - | - | - |
| **Profit before impairment** | **603** | **621** | **534** | **427** | **454** | **424** | **398** | **409** |
| Credit impairment charges | (367) | (431) | (379) | (312) | (399) | (298) | (276) | (309) |
| **Profit before tax** | **236** | **190** | **155** | **115** | **55** | **126** | **122** | **100** |
| Attributable profit | 176 | 144 | 118 | 87 | 41 | 94 | 89 | 75 |
| **Balance sheet information** | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Loans and advances to customers at amortised cost | 21.0 | 21.1 | 20.0 | 18.2 | 18.8 | 20.0 | 23.2 | 24.3 |
| Deposits at amortised cost | 25.0 | 24.2 | 23.7 | 22.5 | 23.8 | 23.3 | 19.4 | 20.0 |
| Risk weighted assets | 27.6 | 27.4 | 25.8 | 24.7 | 25.6 | 26.8 | 23.2 | 24.4 |
| Period end allocated tangible equity | 3.8 | 3.8 | 3.5 | 3.4 | 3.5 | 3.7 | 3.2 | 3.3 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Return on average allocated tangible equity | 18.8% | 15.8% | 13.5% | 10.2% | 4.5% | 11.2% | 10.9% | 9.2% |
| Average allocated tangible equity (£bn) | 3.8 | 3.6 | 3.5 | 3.4 | 3.6 | 3.4 | 3.3 | 3.3 |
| Cost: income ratio | 39% | 41% | 43% | 48% | 47% | 51% | 50% | 50% |
| Loan loss rate (bps)<sup>1</sup> | 491 | 558 | 505 | 456 | 562 | 395 | 411 | 438 |
| Net interest margin | 12.76% | 11.63% | 11.50% | 10.83% | 10.53% | 10.66% | 10.38% | 10.43% |

---

 *1* *LLR includes held for sale portfolios to remain consistent with the treatment of impairment.*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Head Office** |  |  |  |  |  |  |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Income statement information** | £m | £m | £m | £m | £m | £m | £m | £m |
| Net interest income | (53) | (11) | 138 | 114 | 174 | 183 | 215 | 62 |
| Net fee, commission and other income | 70 | 94 | (105) | (43) | (109) | (107) | (27) | (226) |
| **Total income** | **17** | **83** | **33** | **71** | **65** | **76** | **188** | **(164)** |
| Operating costs | (205) | (203) | (162) | (175) | (207) | (233) | (197) | (195) |
| UK regulatory levies | - | (8) | - | - | - | (9) | - | - |
| Litigation and conduct | (107) | (13) | (239) | (2) | (3) | (84) | (7) | 1 |
| **Total operating expenses** | **(312)** | **(224)** | **(401)** | **(177)** | **(210)** | **(326)** | **(204)** | **(194)** |
| Other net income/(expenses) | 21 | (25) | 39 | (9) | 18 | - | 21 | 4 |
| **(Loss)/profit before impairment** | **(274)** | **(166)** | **(329)** | **(115)** | **(127)** | **(250)** | **5** | **(354)** |
| Credit impairment releases/(charges) | 2 | (5) | (1) | (1) | (4) | (42) | (19) | (18) |
| **Loss before tax** | **(272)** | **(171)** | **(330)** | **(116)** | **(131)** | **(292)** | **(14)** | **(372)** |
| Attributable loss | (206) | (152) | (299) | (114) | (124) | (318) | (16) | (349) |
| **Balance sheet information** | £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>|
| Risk weighted assets | 12.3 | 12.3 | 12.7 | 12.6 | 12.7 | 16.2 | 16.1 | 18.3 |
| Period end allocated tangible equity | 5.4 | 7.5 | 5.8 | 5.9 | 4.7 | 2.4 | 4.9 | 2.7 |
| **Performance measures** |  |  |  |  |  |  |  |  |
| Average allocated tangible equity (£bn) | 6.8 | 6.7 | 6.6 | 5.5 | 3.8 | 3.4 | 3.5 | 2.1 |

---

 **Performance Management**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Margins and balances**<br>|  |  |  |  |  |  |
|  | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** |
|  | **Net interest income** | **Average customer assets** | **Net interest margin** | **Net interest income** | **Average customer assets** | **Net interest margin** |
|  | £m | £m | % | £m | £m | % |
| Barclays UK<br>| 1986<br>| 216623<br>| 3.72<br>| 1822<br>| 208305<br>| 3.55<br>|
| Barclays UK Corporate Bank<br>| 394<br>| 28536<br>| 5.60<br>| 342<br>| 24605<br>| 5.64<br>|
| Barclays Private Bank and Wealth Management<br>| 204 | 15022<br>| 5.51<br>| 204<br>| 14674<br>| 5.64<br>|
| Barclays US Consumer Bank<sup>1</sup><br>| 823<br>| 26163<br>| 12.76<br>| 678<br>| 26106<br>| 10.53<br>|
| **Group excluding IB and Head Office<sup>1</sup>**<br>| **3407**<br>| **286344**<br>| **4.83**<br>| **3046**<br>| **273690**<br>| **4.51**<br>|
| Barclays Investment Bank<br>| 383<br>|  |  | 297<br>|  |  |
| Head Office<br>| (53)<br>|  |  | 174<br>|  |  |
| **Barclays Group Net interest income**<br>| **3737**<br>|  |  | **3517**<br>|  |  |

---

The Group excluding IB and Head Office net interest margin increased by 32bps from 4.51% in Q125 to 4.83% in Q126 due to higher Group structural hedge income and partner reward updates in USCB.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Quarterly analysis** | **Quarterly analysis** | **Quarterly analysis** | **Quarterly analysis** |  |  |
|  | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** |
| **Net interest income** | £m | £m | £m | £m | £m |
| Barclays UK<br>| 1986 | 2015<br>| 1961<br>| 1855<br>| 1822<br>|
| Barclays UK Corporate Bank<br>| 394 | 396<br>| 383<br>| 359<br>| 342<br>|
| Barclays Private Bank and Wealth Management<br>| 204 | 202<br>| 190<br>| 203<br>| 204<br>|
| Barclays US Consumer Bank<br>| 823 | 776<br>| 726<br>| 640<br>| 678<br>|
| **Group excluding IB and Head Office**<br>| **3407** | **3389**<br>| **3260**<br>| **3057**<br>| **3046**<br>|
| **Average customer assets**<br>| £m | £m | £m | £m | £m |
| Barclays UK<br>| 216623 | 214770<br>| 211384<br>| 209649<br>| 208305<br>|
| Barclays UK Corporate Bank<br>| 28536 | 27841<br>| 26645<br>| 25478<br>| 24605<br>|
| Barclays Private Bank and Wealth Management<br>| 15022 | 15105<br>| 14802<br>| 14729<br>| 14674<br>|
| Barclays US Consumer Bank<sup>1</sup><br>| 26163 | 26470<br>| 25037<br>| 23713<br>| 26106<br>|
| **Group excluding IB and Head Office<sup>1</sup>**<br>| **286344** | **284186**<br>| **277868**<br>| **273569**<br>| **273690**<br>|
| **Net interest margin** | % | % | % | % | % |
| Barclays UK<br>| 3.72<br>| 3.72<br>| 3.68<br>| 3.55<br>| 3.55<br>|
| Barclays UK Corporate Bank<br>| 5.60<br>| 5.64<br>| 5.70<br>| 5.65<br>| 5.64<br>|
| Barclays Private Bank and Wealth Management<br>| 5.51<br>| 5.31<br>| 5.09<br>| 5.53<br>| 5.64<br>|
| Barclays US Consumer Bank<br>| 12.76<br>| 11.63<br>| 11.50<br>| 10.83<br>| 10.53<br>|
| **Group excluding IB and Head Office** | **4.83** | **4.73** | **4.65** | **4.48** | **4.51** |

---

 *1* *Includes average customer asset balances classified as held for sale.*

 **Structural hedge**

The Group employs a structural hedge programme designed to stabilise NIM on fixed rate non-maturity balance sheet items that are behaviourally stable. As interest rates move, such balances would otherwise drive material income volatility where there is a re-pricing mismatch with floating rate assets.

The structural hedge predominantly covers non-interest-bearing current accounts and the fixed portion of instant access savings accounts as well as equity, which are invested into either floating rate customer assets or balances at central banks, creating an exposure to changes in interest rates. The structural hedge is executed via a portfolio of receive-fixed, pay variable interest rate swaps, with an amortising structure so that a small portion matures and is reinvested each month at prevailing market rates. The pay-floating leg of the interest rate swaps nets down a proportion of the receive-floating income from the customer assets, leaving a receive-fixed income stream from the structural hedge.

The purpose of the structural hedge is to smooth the Group NII through time. The floating leg of the swap will re-price immediately, whereas the fixed rate yield on the portfolio reprices gradually, as a portion of the swap portfolio matures and the roll is re-invested onto new market rates.

When interest rates are higher than our structural hedge yield, the pay-floating rate will typically be higher than our average receive-fixed rate. In this scenario, when viewed in isolation, the structural hedge will be a net drag to Group NII. When floating rates are lower than our structural hedge yield, the hedge in isolation will be a net benefit.

Since the receive-fixed swaps are booked for a specific term, an element of NII is 'locked in'. The income stabilising feature of the structural hedge provides greater net interest income certainty through the interest rate cycle.

The structural hedge is one component of a larger portfolio of interest rate risk management activities that includes non-structural hedging (e.g. pay-fixed and receive-variable flows for asset hedging), and other offsetting flows. The net risk of these positions is executed externally through interest rate swaps and managed for accounting risk (i.e. income volatility arising from the accounting mismatch of swaps at fair value through profit and loss and underlying hedged items at amortised cost) within the cash flow hedging reserve.

Overall the Group has external derivatives designated as cash flow hedges that hedge interest rate risk with a notional £120.9bn (December 2025: £114.6bn) which reflects the structural hedge notional of £241.8bn (December 2025: £236.1bn) netted with non-structural hedging positions of £120.9bn (December 2025: £121.5bn). The majority of these interest rate swaps are cleared with Central Clearing Counterparties and margined daily with an average structural hedge duration of c3.5 years.

Gross structural hedge contributions in Q126 were £1,660m (Q125: £1,335m). Gross structural hedge contributions represent the absolute interest income earned on the fixed legs of the swaps in the structural hedge as the floating leg is offset by the base rate funding of the deposits.

 **Credit Risk**

 **Loans and advances at amortised cost by geography**

Total loans and advances at amortised cost in the credit risk section includes loans and advances at amortised cost to banks and loans and advances at amortised cost to customers.

The table below presents a product and geographical breakdown of loans and advances at amortised cost and the impairment allowance by stage; and includes purchased or originated credit-impaired (POCI) balances. POCI balances represent a fixed pool of assets purchased at a deep discount to face value reflecting credit losses incurred from the point of origination to date of acquisition. The table also presents stage allocation of debt securities and off-balance sheet loan commitments and financial guarantee contracts.

The impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** |
|  | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** |
| **As at 31.03.26** | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| Retail mortgages | 161120 | 13982 | 1883 | - | 176985 | 12 | 19 | 64 | - | 95 |
| Retail credit cards | 14657 | 2024 | 291 | 18 | 16990 | 176 | 425 | 183 | - | 784 |
| Retail other | 9906 | 1526 | 322 | 11 | 11765 | 109 | 175 | 214 | - | 498 |
| Corporate loans<sup>1</sup> | 56541 | 6037 | 1650 | - | 64228 | 116 | 169 | 670 | - | 955 |
| **Total UK** | **242224** | **23569** | **4146** | **29** | **269968** | **413** | **788** | **1131** | **-** | **2332** |
| Retail mortgages | 1838 | 31 | 158 | - | 2027 | 2 | - | 24 | - | 26 |
| Retail credit cards | 18547 | 2651 | 1842 | - | 23040 | 394 | 791 | 1488 | - | 2673 |
| Retail other | 2462 | 260 | 61 | - | 2783 | 5 | 5 | 20 | - | 30 |
| Corporate loans | 71802 | 4533 | 1732 | - | 78067 | 76 | 150 | 296 | - | 522 |
| **Total Rest of the World** | **94649** | **7475** | **3793** | **-** | **105917** | **477** | **946** | **1828** | **-** | **3251** |
| **Total loans and advances at amortised cost** | **336873** | **31044** | **7939** | **29** | **375885** | **890** | **1734** | **2959** | **-** | **5583** |
| Debt securities at amortised cost | 67940 | 404 | - | - | 68344 | 9 | 10 | - | - | 19 |
| **Total loans and advances at amortised cost including debt securities** | **404813** | **31448** | **7939** | **29** | **444229** | **899** | **1744** | **2959** | **-** | **5602** |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 420832 | 16039 | 857 | 5 | 437733 | 148 | 245 | 32 | - | 425 |
| **Total<sup>3,4</sup>** | **825645** | **47487** | **8796** | **34** | **881962** | **1047** | **1989** | **2991** | **-** | **6027** |
|  | **Net exposure** | **Net exposure** | **Net exposure** | **Net exposure** | **Net exposure** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** |
|  | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** |
| **As at 31.03.26** | £m | £m | £m | £m | £m | % | % | % | % | % |
| Retail mortgages | 161108 | 13963 | 1819 | - | 176890 | - | 0.1 | 3.4 | - | 0.1 |
| Retail credit cards | 14481 | 1599 | 108 | 18 | 16206 | 1.2 | 21.0 | 62.9 | - | 4.6 |
| Retail other | 9797 | 1351 | 108 | 11 | 11267 | 1.1 | 11.5 | 66.5 | - | 4.2 |
| Corporate loans<sup>1</sup> | 56425 | 5868 | 980 | - | 63273 | 0.2 | 2.8 | 40.6 | - | 1.5 |
| **Total UK** | **241811** | **22781** | **3015** | **29** | **267636** | **0.2** | **3.3** | **27.3** | **-** | **0.9** |
| Retail mortgages | 1836 | 31 | 134 | - | 2001 | 0.1 | - | 15.2 | - | 1.3 |
| Retail credit cards | 18153 | 1860 | 354 | - | 20367 | 2.1 | 29.8 | 80.8 | - | 11.6 |
| Retail other | 2457 | 255 | 41 | - | 2753 | 0.2 | 1.9 | 32.8 | - | 1.1 |
| Corporate loans | 71726 | 4383 | 1436 | - | 77545 | 0.1 | 3.3 | 17.1 | - | 0.7 |
| **Total Rest of the World** | **94172** | **6529** | **1965** | **-** | **102666** | **0.5** | **12.7** | **48.2** | **-** | **3.1** |
| **Total loans and advances at amortised cost** | **335983** | **29310** | **4980** | **29** | **370302** | 0.3 | 5.6 | 37.3 | - | **1.5** |
| Debt securities at amortised cost | 67931 | 394 | - | - | 68325 | - | 2.5 | - | - | - |
| **Total loans and advances at amortised cost including debt securities** | **403914** | **29704** | **4980** | **29** | **438627** | **0.2** | **5.5** | **37.3** | **-** | **1.3** |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 420684 | 15794 | 825 | 5 | 437308 | - | 1.5 | 3.7 | - | 0.1 |
| **Total<sup>3,4</sup>** | **824598** | **45498** | **5805** | **34** | **875935** | **0.1** | **4.2** | **34.0** | **-** | **0.7** |

---

---

| | |
|:---|:---|
| *1* | *Includes Business Banking, which has a gross exposure of £12.4bn and an impairment allowance of £318m. This comprises £60m impairment allowance on £9.7bn Stage 1 exposure, £51m on £2.1bn Stage 2 exposure and £207m on £0.6bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 1.2%.* |
| *2* | *Excludes loan commitments and financial guarantees of £25.4bn carried at fair value and includes exposure relating to financial assets classified as assets held for sale.* |
| *3* | *Other financial assets subject to impairment excluded in the table above include cash collateral and settlement balances, reverse repurchase agreements and other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £293.7bn and an impairment allowance of £151m. This comprises £18m impairment allowance on £292.8bn Stage 1 exposure, £8m on £0.8bn Stage 2 exposure and £125m on £128m Stage 3 exposure.* |
| *4* | *The annualised loan loss rate is 74bps after applying the total impairment charge of £823m.* |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Gross exposure** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** | **Impairment allowance** |
|  | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** |
| **As at 31.12.25** | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| Retail mortgages | 159825 | 13757 | 1836 | - | 175418 | 15 | 16 | 60 | - | 91 |
| Retail credit cards | 14922 | 1943 | 279 | 24 | 17168 | 171 | 398 | 174 | - | 743 |
| Retail other | 9867 | 1512 | 286 | 15 | 11680 | 98 | 178 | 214 | - | 490 |
| Corporate loans<sup>1</sup> | 54182 | 6936 | 1392 | - | 62510 | 125 | 180 | 422 | - | 727 |
| **Total UK** | **238796** | **24148** | **3793** | **39** | **266776** | **409** | **772** | **870** | **-** | **2051** |
| Retail mortgages | 1829 | 72 | 131 | - | 2032 | 2 | - | 24 | - | 26 |
| Retail credit cards | 18801 | 2536 | 1776 | - | 23113 | 395 | 796 | 1395 | - | 2586 |
| Retail other | 2482 | 206 | 63 | - | 2751 | 3 | 5 | 19 | - | 27 |
| Corporate loans | 66671 | 3702 | 1767 | - | 72140 | 82 | 135 | 382 | - | 599 |
| **Total Rest of the World** | **89783** | **6516** | **3737** | **-** | **100036** | **482** | **936** | **1820** | **-** | **3238** |
| **Total loans and advances at amortised cost** | **328579** | **30664** | **7530** | **39** | **366812** | **891** | **1708** | **2690** | **-** | **5289** |
| Debt securities at amortised cost | 68126 | 371 | - | - | 68497 | 13 | 9 | - | - | 22 |
| **Total loans and advances at amortised cost including debt securities** | **396705** | **31035** | **7530** | **39** | **435309** | **904** | **1717** | **2690** | **-** | **5311** |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 410493 | 16473 | 812 | 5 | 427783 | 144 | 240 | 32 | - | 416 |
| **Total<sup>3,4</sup>** | **807198** | **47508** | **8342** | **44** | **863092** | **1048** | **1957** | **2722** | **-** | **5727** |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Net exposure** | **Net exposure** | **Net exposure** | **Net exposure** | **Net exposure** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** | **Coverage ratio** |
|  | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** | **Stage 1** | **Stage 2** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** |
| **As at 31.12.25** | £m | £m | £m | £m | £m | % | % | % | % | % |
| Retail mortgages | 159810 | 13741 | 1776 | - | 175327 | - | 0.1 | 3.3 | - | 0.1 |
| Retail credit cards | 14751 | 1545 | 105 | 24 | 16425 | 1.1 | 20.5 | 62.4 | - | 4.3 |
| Retail other | 9769 | 1334 | 72 | 15 | 11190 | 1.0 | 11.8 | 74.8 | - | 4.2 |
| Corporate loans<sup>1</sup> | 54057 | 6756 | 970 | - | 61783 | 0.2 | 2.6 | 30.3 | - | 1.2 |
| **Total UK** | **238387** | **23376** | **2923** | **39** | **264725** | **0.2** | **3.2** | **22.9** | **-** | **0.8** |
| Retail mortgages | 1827 | 72 | 107 | - | 2006 | 0.1 | - | 18.3 | - | 1.3 |
| Retail credit cards | 18406 | 1740 | 381 | - | 20527 | 2.1 | 31.4 | 78.5 | - | 11.2 |
| Retail other | 2479 | 201 | 44 | - | 2724 | 0.1 | 2.4 | 30.2 | - | 1.0 |
| Corporate loans | 66589 | 3567 | 1385 | - | 71541 | 0.1 | 3.6 | 21.6 | - | 0.8 |
| **Total Rest of the World** | **89301** | **5580** | **1917** | **-** | **96798** | **0.5** | **14.4** | **48.7** | **-** | **3.2** |
| **Total loans and advances at amortised cost** | **327688** | **28956** | **4840** | **39** | **361523** | 0.3 | 5.6 | 35.7 | - | **1.4** |
| Debt securities at amortised cost | 68113 | 362 | - | - | 68475 | - | 2.4 | - | - | - |
| **Total loans and advances at amortised cost including debt securities** | **395801** | **29318** | **4840** | **39** | **429998** | **0.2** | **5.5** | **35.7** | **-** | **1.2** |
| Off-balance sheet loan commitments and financial guarantee contracts<sup>2</sup> | 410349 | 16233 | 780 | 5 | 427367 | - | 1.5 | 3.9 | - | 0.1 |
| **Total<sup>3,4</sup>** | **806150** | **45551** | **5620** | **44** | **857365** | **0.1** | **4.1** | **32.6** | **-** | **0.7** |

---

---

| | |
|:---|:---|
| *1* | *Includes Business Banking, which has a gross exposure of £12.4bn and an impairment allowance of £326m. This comprises £62m impairment allowance on £9.3bn Stage 1 exposure, £50m on £2.3bn Stage 2 exposure and £214m on £0.8bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 0.8%.* |
| *2* | *Excludes loan commitments and financial guarantees of £22.2bn carried at fair value and includes exposure relating to financial assets classified as assets held for sale.* |
| *3* | *Other financial assets subject to impairment excluded in the table above include cash collateral and settlement balances, reverse repurchase agreements and other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £224.1bn and an impairment allowance of £150m. This comprises £18m impairment allowance on £222.4bn Stage 1 exposure, £8m on £1.6bn Stage 2 exposure and £124m on £127m Stage 3 exposure.* |
| *4* | *The annualised loan loss rate is 52bps after applying the total impairment charge of £2,279m.* |

---

 **Assets held for sale**

This section presents a co-branded card portfolio in USCB classified as assets held for sale.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** | **Loans and advances to customers classified as assets held for sale** |
|  | **Stage 1** | **Stage 1** | **Stage 1** | **Stage 2** | **Stage 2** | **Stage 2** | **Stage 3** | **Stage 3** | **Stage 3** | **Total** | **Total** | **Total** |
|  | **Gross** | **ECL** | **Coverage** | **Gross** | **ECL** | **Coverage** | **Gross** | **ECL** | **Coverage** | **Gross** | **ECL** | **Coverage** |
| **As at 31.03.26** | £m | £m | % | £m | £m | % | £m | £m | % | £m | £m | % |
| Retail credit cards - US | 5061<br>| 66<br>| 1.3<br>| 484<br>| 122<br>| 25.2<br>| 57<br>| 47<br>| 82.5<br>| 5602<br>| 235<br>| 4.2<br>|
| Corporate loans - US | 44<br>| 1<br>| 2.3<br>| 6<br>| 2<br>| 33.3<br>| -<br>| -<br>| -<br>| 50<br>| 3<br>| 6.0<br>|
| **Total Rest of the World** | **5105**<br>| **67**<br>| **1.3**<br>| **490**<br>| **124**<br>| **25.3**<br>| **57**<br>| **47**<br>| **82.5**<br>| **5652**<br>| **238**<br>| **4.2**<br>|
| **As at 31.12.25** |  |  |  |  |  |  |  |  |  |  |  |  |
| Retail credit cards - US | 5468<br>| 65<br>| 1.2<br>| 466<br>| 124<br>| 26.6<br>| 54<br>| 44<br>| 81.5<br>| 5988<br>| 233<br>| 3.9<br>|
| Corporate loans - US | 43<br>| 1<br>| 2.3<br>| 6<br>| 2<br>| 33.3<br>| -<br>| -<br>| -<br>| 49<br>| 3<br>| 6.1<br>|
| **Total Rest of the World** | **5511**<br>| **66**<br>| **1.2**<br>| **472**<br>| **126**<br>| **26.7**<br>| **54**<br>| **44**<br>| **81.5**<br>| **6037**<br>| **236**<br>| **3.9**<br>|

---

 **Loans and advances at amortised cost by product**

The table below presents a product breakdown by stages of loans and advances at amortised cost. Also included is a breakdown of Stage 2 past due balances.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Stage 2** | **Stage 2** | **Stage 2** | **Stage 2** |  |  |  |
| **As at 31.03.26** | **Stage 1** | **Not past due** | **<=30 days past due** | **>30 days past due** | **Total** | **Stage 3 excluding POCI** | **Stage 3 POCI** | **Total** |
| **Gross exposure** | £m | £m | £m | £m | £m | £m | £m | £m |
| Retail mortgages<br>| 162958 | 10682 | 2559 | 772 | 14013 | 2041 | - | 179012 |
| Retail credit cards<br>| 33204 | 4006 | 362 | 307 | 4675 | 2133 | 18 | 40030 |
| Retail other<br>| 12368 | 1394 | 185 | 207 | 1786 | 383 | 11 | 14548 |
| Corporate loans<br>| 128343 | 10271 | 104 | 195 | 10570 | 3382 | - | 142295 |
| **Total** | **336873** | **26353** | **3210** | **1481** | **31044** | **7939** | **29** | **375885** |
| **Impairment allowance**<br>|  |  |  |  |  |  |  |  |
| Retail mortgages<br>| 14 | 10 | 6 | 3 | 19 | 88 | - | 121 |
| Retail credit cards<br>| 570 | 856 | 157 | 203 | 1216 | 1671 | - | 3457 |
| Retail other<br>| 114 | 117 | 32 | 31 | 180 | 234 | - | 528 |
| Corporate loans<br>| 192 | 300 | 12 | 7 | 319 | 966 | - | 1477 |
| **Total** | **890** | **1283** | **207** | **244** | **1734** | **2959** | **-** | **5583** |
| **Net exposure**<br>|  |  |  |  |  |  |  |  |
| Retail mortgages<br>| 162944 | 10672 | 2553 | 769 | 13994 | 1953 | - | 178891 |
| Retail credit cards<br>| 32634 | 3150 | 205 | 104 | 3459 | 462 | 18 | 36573 |
| Retail other<br>| 12254 | 1277 | 153 | 176 | 1606 | 149 | 11 | 14020 |
| Corporate loans<br>| 128151 | 9971 | 92 | 188 | 10251 | 2416 | - | 140818 |
| **Total** | **335983** | **25070** | **3003** | **1237** | **29310** | **4980** | **29** | **370302** |
| **Coverage ratio**<br>| % | % | % | % | % | % | % | % |
| Retail mortgages<br>| - | 0.1 | 0.2 | 0.4 | 0.1 | 4.3 | - | 0.1 |
| Retail credit cards<br>| 1.7 | 21.4 | 43.4 | 66.1 | 26.0 | 78.3 | - | 8.6 |
| Retail other<br>| 0.9 | 8.4 | 17.3 | 15.0 | 10.1 | 61.1 | - | 3.6 |
| Corporate loans<br>| 0.1 | 2.9 | 11.5 | 3.6 | 3.0 | 28.6 | - | 1.0 |
| **Total** | **0.3** | **4.9** | **6.4** | **16.5** | **5.6** | **37.3** | **-** | **1.5** |
| **As at 31.12.25**<br>|  |  |  |  |  |  |  |  |
| **Gross exposure**<br>| £m | £m | £m | £m | £m | £m | £m | £m |
| Retail mortgages<br>| 161654 | 11072 | 2033 | 724 | 13829 | 1967 | - | 177450 |
| Retail credit cards<br>| 33723 | 3832 | 317 | 330 | 4479 | 2055 | 24 | 40281 |
| Retail other<br>| 12349 | 1398 | 207 | 113 | 1718 | 349 | 15 | 14431 |
| Corporate loans<br>| 120853 | 10409 | 71 | 158 | 10638 | 3159 | - | 134650 |
| **Total** | **328579** | **26711** | **2628** | **1325** | **30664** | **7530** | **39** | **366812** |
| **Impairment allowance**<br>|  |  |  |  |  |  |  |  |
| Retail mortgages<br>| 17 | 9 | 4 | 3 | 16 | 84 | - | 117 |
| Retail credit cards<br>| 566 | 840 | 138 | 216 | 1194 | 1569 | - | 3329 |
| Retail other<br>| 101 | 126 | 28 | 29 | 183 | 233 | - | 517 |
| Corporate loans<br>| 207 | 298 | 7 | 10 | 315 | 804 | - | 1326 |
| **Total** | **891** | **1273** | **177** | **258** | **1708** | **2690** | **-** | **5289** |
| **Net exposure**<br>|  |  |  |  |  |  |  |  |
| Retail mortgages<br>| 161637 | 11063 | 2029 | 721 | 13813 | 1883 | - | 177333 |
| Retail credit cards<br>| 33157 | 2992 | 179 | 114 | 3285 | 486 | 24 | 36952 |
| Retail other<br>| 12248 | 1272 | 179 | 84 | 1535 | 116 | 15 | 13914 |
| Corporate loans<br>| 120646 | 10111 | 64 | 148 | 10323 | 2355 | - | 133324 |
| **Total** | **327688** | **25438** | **2451** | **1067** | **28956** | **4840** | **39** | **361523** |
| **Coverage ratio**<br>| % | % | % | % | % | % | % | % |
| Retail mortgages<br>| - | 0.1 | 0.2 | 0.4 | 0.1 | 4.3 | - | 0.1 |
| Retail credit cards<br>| 1.7 | 21.9 | 43.5 | 65.5 | 26.7 | 76.4 | - | 8.3 |
| Retail other<br>| 0.8 | 9.0 | 13.5 | 25.7 | 10.7 | 66.8 | - | 3.6 |
| Corporate loans<br>| 0.2 | 2.9 | 9.9 | 6.3 | 3.0 | 25.5 | - | 1.0 |
| **Total** | **0.3** | **4.8** | **6.7** | **19.5** | **5.6** | **35.7** | **-** | **1.4** |

---

 **Measurement uncertainty**

Scenarios used to calculate the Group's modelled ECL charge were refreshed in Q126, with the Baseline scenario reflecting the latest consensus macroeconomic forecasts available at the time of the scenario refresh which predated the most recent geopolitical escalation. However, the assessment of ECL includes continued use of management judgement in overlaying modelled outcomes to capture risks not fully reflected in forward-looking macroeconomic assumptions.

The Baseline scenario continues to reflect the rapidly changing trade policies of the US administration and ongoing geopolitical uncertainty. Global growth slows modestly as rising US tariffs and retaliatory measures disrupt trade flows, dampen business confidence, and weigh on investment, though domestic demand in advanced economies remains resilient. UK and US GDP growth in 2026 is expected to be 1.0% and 2.4%, respectively. Tariff-induced and supply side pressures cause headline inflation to remain stickier in the near term. Labour markets in major economies soften slightly amid increased uncertainty and slower export-orientated activity; however, the weakening is contained and does not rise significantly from current levels. UK and US quarterly unemployment rates peak at 5.2% and 4.5%, respectively.

The Downside scenarios have been calibrated to capture an escalation of trade tensions, where tariffs imposed by the US prompt retaliation from its trading partners with adverse implications for consumer prices and investment sentiment, and ongoing geopolitical uncertainty. The combination of trade impact and consumer uncertainty triggers a sharp recession, not only in the US but also in the UK and Europe driven by a severe decline in exports, business sentiment and with investment and consumption plans being put on hold. The rapid fall in external demand and a retrenchment in business investment push up unemployment rates, where job losses are concentrated in trade-exposed sectors but also spill into services. The Federal Reserve initially holds rates steady, weighing the inflation shock against the deteriorating real economy. However, as the slowdown deepens and the labour market loosens, the Federal Reserve cuts rates swiftly to stimulate aggregate demand.

In the Upside scenarios, a rise in labour force participation and higher productivity contribute to accelerated economic growth, without creating new inflationary pressures. Central banks lower interest rates stimulating private consumption and investment growth. Demand for labour increases and unemployment rates stabilise and start falling again. As geopolitical tensions ease, low inflation supports consumer purchasing power and contributes further to healthy GDP growth.

The methodology for estimating scenario weights involves simulating a range of future paths for UK and US GDP using historical data with the five scenarios mapped against the distribution of these future paths. The small increase in Upside weights is driven by improvement in UK and US GDP outlook. in the Baseline scenario, bringing the Baseline scenario closer to the Upside scenarios. For further details see page 31.

The refreshed scenarios predate the most recent geopolitical escalation, and so may not reflect the potential associated near-term impacts including supply chain disruption, higher energy prices and rising inflation. In response, management adjustments of £101m have been introduced, partially offset by the release of £81m tariff-related adjustments raised in Q125, resulting in a net additional charge of £20m.

● Within Barclays UK, a £10m adjustment has been recognised in
the Retail credit cards portfolio, reflecting a marginally weaker
UK unemployment baseline than that assumed in the Q126
macroeconomic scenario.

● For USCB, the tariff-related adjustment from Q125 of
£31m <sup>1</sup> was
released due to the lack of tariff-driven credit deterioration and
losses. However, uncertainty persists and has been reflected
through holding back a £25m <sup>1</sup> release
arising from the Q126 macroeconomic scenario.

● In IB, the tariff-related adjustment from Q125 of £50m
(£35m net of SRT <sup>2</sup> credit
protection) was released due to the lack of tariff-driven credit
deterioration and losses. However, geopolitical uncertainty
persists and has been reflected through a management adjustment of
£66m (£52m net of SRT <sup>2</sup> credit
protection) to capture increased downside risk.

The following tables show the key macroeconomic variables used in the five scenarios (5-year annual paths) and the weights applied to each scenario.

---

| | |
|:---|:---|
| *1* | *Excludes adjustments for held for sale portfolio comprising a £5m tariff-related adjustment from Q125 and a £4m adjustment from the Q126 macroeconomic scenario.* |
| *2* | *Significant Risk Transfer (SRT) represents risk transfer transactions used to enhance risk management capabilities.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Macroeconomic variables used in the calculation of ECL** | **Macroeconomic variables used in the calculation of ECL** | **Macroeconomic variables used in the calculation of ECL** | **Macroeconomic variables used in the calculation of ECL** | **Macroeconomic variables used in the calculation of ECL** | **Macroeconomic variables used in the calculation of ECL** |
| **As at 31.03.26** | **2026** | **2027** | **2028** | **2029** | **2030** |
| **Baseline** | % | % | % | % | % |
| UK GDP<sup>1</sup><br>| 1.0 | 1.5 | 1.4 | 1.4 | 1.5 |
| UK unemployment<sup>2</sup><br>| 5.2 | 5.0 | 5.0 | 4.9 | 4.9 |
| UK HPI<sup>3</sup><br>| 1.9 | 2.6 | 3.4 | 3.4 | 3.6 |
| UK bank rate<sup>6</sup><br>| 3.4 | 3.3 | 3.5 | 3.6 | 3.8 |
| US GDP<sup>1</sup><br>| 2.4 | 2.0 | 2.0 | 2.0 | 2.0 |
| US unemployment<sup>4</sup><br>| 4.4 | 4.3 | 4.3 | 4.3 | 4.3 |
| US HPI<sup>5</sup><br>| 2.7 | 2.1 | 2.4 | 2.4 | 2.4 |
| US federal funds rate<sup>6</sup><br>| 3.4 | 3.0 | 3.2 | 3.3 | 3.5 |
| **Downside 2** |  |  |  |  |  |
| UK GDP<sup>1</sup><br>| (1.2) | (2.8) | 2.8 | 1.3 | 0.9 |
| UK unemployment<sup>2</sup><br>| 5.5 | 7.3 | 7.4 | 5.9 | 5.3 |
| UK HPI<sup>3</sup><br>| (16.9) | (14.1) | 4.6 | 16.9 | 8.4 |
| UK bank rate<sup>6</sup><br>| 2.8 | 0.8 | 0.2 | 0.9 | 1.7 |
| US GDP<sup>1</sup><br>| (0.5) | (4.3) | 1.0 | 2.5 | 1.2 |
| US unemployment<sup>4</sup><br>| 5.1 | 7.5 | 8.3 | 6.2 | 5.4 |
| US HPI<sup>5</sup><br>| (4.0) | (4.9) | 5.2 | 9.2 | 4.6 |
| US federal funds rate<sup>6</sup><br>| 3.8 | 2.7 | 1.6 | 1.1 | 1.8 |
| **Downside 1** |  |  |  |  |  |
| UK GDP<sup>1</sup><br>| (0.1) | (0.7) | 2.1 | 1.3 | 1.2 |
| UK unemployment<sup>2</sup><br>| 5.4 | 6.2 | 6.2 | 5.4 | 5.1 |
| UK HPI<sup>3</sup><br>| (7.8) | (5.9) | 4.0 | 10.0 | 6.0 |
| UK bank rate<sup>6</sup><br>| 3.2 | 2.2 | 2.1 | 2.4 | 2.9 |
| US GDP<sup>1</sup><br>| 0.9 | (1.1) | 1.5 | 2.3 | 1.6 |
| US unemployment<sup>4</sup><br>| 4.8 | 5.9 | 6.3 | 5.3 | 4.8 |
| US HPI<sup>5</sup><br>| (0.7) | (1.5) | 3.8 | 5.7 | 3.5 |
| US federal funds rate<sup>6</sup><br>| 3.6 | 2.9 | 2.6 | 2.3 | 2.9 |
| **Upside 2** |  |  |  |  |  |
| UK GDP<sup>1</sup><br>| 1.8 | 4.0 | 3.1 | 2.5 | 2.3 |
| UK unemployment<sup>2</sup><br>| 4.8 | 4.2 | 4.1 | 4.0 | 4.0 |
| UK HPI<sup>3</sup><br>| 8.6 | 11.0 | 5.8 | 3.4 | 3.0 |
| UK bank rate<sup>6</sup><br>| 3.2 | 2.4 | 2.3 | 2.6 | 2.8 |
| US GDP<sup>1</sup><br>| 2.7 | 3.2 | 2.8 | 2.8 | 2.8 |
| US unemployment<sup>4</sup><br>| 4.1 | 3.6 | 3.6 | 3.6 | 3.6 |
| US HPI<sup>5</sup><br>| 6.5 | 4.2 | 5.0 | 4.9 | 4.9 |
| US federal funds rate<sup>6</sup><br>| 3.2 | 2.3 | 2.4 | 2.5 | 2.5 |
| **Upside 1** |  |  |  |  |  |
| UK GDP<sup>1</sup><br>| 1.4 | 2.7 | 2.2 | 1.9 | 1.9 |
| UK unemployment<sup>2</sup><br>| 5.0 | 4.6 | 4.6 | 4.5 | 4.5 |
| UK HPI<sup>3</sup><br>| 5.2 | 6.8 | 4.6 | 3.4 | 3.3 |
| UK bank rate<sup>6</sup><br>| 3.3 | 3.0 | 3.2 | 3.3 | 3.3 |
| US GDP<sup>1</sup><br>| 2.5 | 2.6 | 2.4 | 2.4 | 2.4 |
| US unemployment<sup>4</sup><br>| 4.3 | 4.0 | 4.0 | 4.0 | 4.0 |
| US HPI<sup>5</sup><br>| 4.6 | 3.2 | 3.7 | 3.6 | 3.6 |
| US federal funds rate<sup>6</sup><br>| 3.4 | 3.0 | 3.2 | 3.2 | 3.0 |

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |
| *6* | *Average rate.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **As at 31.12.25**<br>| **2025** | **2026** | **2027** | **2028** | **2029** |
| **Baseline** | % | % | % | % | % |
| UK GDP<sup>1</sup><br>| 1.5<br>| 1.1<br>| 1.4<br>| 1.4<br>| 1.4<br>|
| UK unemployment<sup>2</sup><br>| 4.7 | 4.9 | 4.8 | 4.8 | 4.7 |
| UK HPI<sup>3</sup><br>| 1.5 | 2.9 | 2.5 | 4.3 | 3.8 |
| UK bank rate<sup>6</sup><br>| 4.2 | 3.4 | 3.4 | 3.5 | 3.6 |
| US GDP<sup>1</sup><br>| 2.1 | 2.0 | 2.0 | 2.0 | 2.0 |
| US unemployment<sup>4</sup><br>| 4.2 | 4.5 | 4.4 | 4.4 | 4.4 |
| US HPI<sup>5</sup><br>| 3.2 | 1.7 | 1.9 | 2.6 | 2.6 |
| US federal funds rate<sup>6</sup><br>| 4.2 | 3.4 | 3.3 | 3.3 | 3.5 |
| **Downside 2**<br>|  |  |  |  |  |
| UK GDP<sup>1</sup><br>| 1.5<br>| (2.5)<br>| (1.2)<br>| 2.8<br>| 1.1<br>|
| UK unemployment<sup>2</sup><br>| 4.7<br>| 5.8<br>| 7.7<br>| 6.9<br>| 5.7<br>|
| UK HPI<sup>3</sup><br>| 1.5<br>| (24.9)<br>| (5.1)<br>| 9.6<br>| 14.2<br>|
| UK bank rate<sup>6</sup><br>| 4.2<br>| 2.3<br>| 0.5<br>| 0.4<br>| 1.1<br>|
| US GDP<sup>1</sup><br>| 2.1<br>| (2.7)<br>| (2.8)<br>| 1.6<br>| 2.4<br>|
| US unemployment<sup>4</sup><br>| 4.2<br>| 5.7<br>| 8.0<br>| 7.9<br>| 5.9<br>|
| US HPI<sup>5</sup><br>| 3.2<br>| (8.2)<br>| (1.7)<br>| 7.2<br>| 7.7<br>|
| US federal funds rate<sup>6</sup><br>| 4.2<br>| 3.6<br>| 2.4<br>| 1.4<br>| 1.2<br>|
| **Downside 1**<br>|  |  |  |  |  |
| UK GDP<sup>1</sup><br>| 1.5<br>| (0.7)<br>| 0.1<br>| 2.1<br>| 1.3<br>|
| UK unemployment<sup>2</sup><br>| 4.7<br>| 5.3<br>| 6.3<br>| 5.8<br>| 5.2<br>|
| UK HPI<sup>3</sup><br>| 1.5<br>| (11.8)<br>| (1.3)<br>| 6.9<br>| 8.9<br>|
| UK bank rate<sup>6</sup><br>| 4.2<br>| 2.9<br>| 2.0<br>| 1.9<br>| 2.4<br>|
| US GDP<sup>1</sup><br>| 2.1<br>| (0.3)<br>| (0.4)<br>| 1.8<br>| 2.2<br>|
| US unemployment<sup>4</sup><br>| 4.2<br>| 5.1<br>| 6.2<br>| 6.1<br>| 5.1<br>|
| US HPI<sup>5</sup><br>| 3.2<br>| (3.3)<br>| 0.1<br>| 4.9<br>| 5.1<br>|
| US federal funds rate<sup>6</sup><br>| 4.2<br>| 3.6<br>| 2.8<br>| 2.4<br>| 2.4<br>|
| **Upside 2**<br>|  |  |  |  |  |
| UK GDP<sup>1</sup><br>| 1.5<br>| 2.7<br>| 3.7<br>| 2.9<br>| 2.4<br>|
| UK unemployment<sup>2</sup><br>| 4.7<br>| 4.3<br>| 4.0<br>| 3.9<br>| 3.8<br>|
| UK HPI<sup>3</sup><br>| 1.5<br>| 11.9<br>| 8.4<br>| 5.1<br>| 4.1<br>|
| UK bank rate<sup>6</sup><br>| 4.2<br>| 3.1<br>| 2.3<br>| 2.3<br>| 2.6<br>|
| US GDP<sup>1</sup><br>| 2.1<br>| 2.8<br>| 3.1<br>| 2.8<br>| 2.8<br>|
| US unemployment<sup>4</sup><br>| 4.2<br>| 3.9<br>| 3.7<br>| 3.7<br>| 3.7<br>|
| US HPI<sup>5</sup><br>| 3.2<br>| 6.2<br>| 4.7<br>| 4.8<br>| 4.9<br>|
| US federal funds rate<sup>6</sup><br>| 4.2<br>| 3.0<br>| 2.5<br>| 2.5<br>| 2.5<br>|
| **Upside 1**<br>|  |  |  |  |  |
| UK GDP<sup>1</sup><br>| 1.5<br>| 1.9<br>| 2.6<br>| 2.2<br>| 1.9<br>|
| UK unemployment<sup>2</sup><br>| 4.7<br>| 4.6<br>| 4.4<br>| 4.4<br>| 4.3<br>|
| UK HPI<sup>3</sup><br>| 1.5<br>| 7.4<br>| 5.4<br>| 4.7<br>| 3.9<br>|
| UK bank rate<sup>6</sup><br>| 4.2<br>| 3.2<br>| 2.8<br>| 2.8<br>| 3.1<br>|
| US GDP<sup>1</sup><br>| 2.1<br>| 2.4<br>| 2.6<br>| 2.4<br>| 2.4<br>|
| US unemployment<sup>4</sup><br>| 4.2<br>| 4.2<br>| 4.1<br>| 4.1<br>| 4.1<br>|
| US HPI<sup>5</sup><br>| 3.2<br>| 4.0<br>| 3.3<br>| 3.7<br>| 3.7<br>|
| US federal funds rate<sup>6</sup><br>| 4.2<br>| 3.3<br>| 2.8<br>| 2.8<br>| 3.0<br>|

---

---

| | |
|:---|:---|
| *1* | *Average Real GDP seasonally adjusted change in year.* |
| *2* | *Average UK unemployment rate 16-year+.* |
| *3* | *Change in year end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year end.* |
| *4* | *Average US civilian unemployment rate 16-year+.* |
| *5* | *Change in year end US HPI = FHFA House Price Index, relative to prior year end.* |
| *6* | *Average rate.* |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Scenario weighting** | **Upside 2** | **Upside 1** | **Baseline** | **Downside 1** | **Downside 2** |
|  | % | % | % | % | % |
| **As at 31.03.26**<br>|  |  |  |  |  |
| Scenario weighting<br>| **14.7** | **27.9** | **38.6** | **12.0** | **6.8** |
| **As at 31.12.25**<br>|  |  |  |  |  |
| Scenario weighting<br>| 14.4<br>| 27.4<br>| 38.5<br>| 12.7<br>| 7.0<br>|

---

 **Treasury and Capital Risk**

 **Regulatory minimum requirements**

 **Capital**

As at 31 March 2026, the Group's Overall Capital Requirement for CET1, excluding any applicable PRA buffer, was 12.2% and comprised a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 1.0% Countercyclical Capital Buffer (CCyB).

The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. The buffer rates set by other national authorities for non-UK exposures are not currently material.

The Group's Pillar 2A requirement is 4.8% with at least 56.25% to be met with CET1 capital, equating to 2.7% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.

The Group's CET1 target ratio of 13-14% takes into account minimum capital requirements and applicable buffers. The Group remains above its minimum capital regulatory requirements and applicable buffers.

 **Leverage**

As at 31 March 2026, the Group was subject to a UK leverage ratio requirement of 4.1%. This comprised the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.3%. The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.

 **MREL**

As at 31 March 2026, the Group was required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.8% Pillar 2A equating to 25.5% of RWAs; and (ii) 6.75% of leverage exposures. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including any applicable confidential institution-specific Prudential Regulation Authority (PRA) buffer, will effectively be applied above MREL requirements.

 **Significant regulatory updates in the period**

In January 2026, the PRA confirmed the final implementation timetable for the UK Basel 3.1 framework. The PRA's final rules reaffirm that Basel 3.1 will be implemented from 1 January 2027.

The PRA also confirmed its approach to the Fundamental Review of the Trading Book (FRTB), under which implementation of the Internal Models Approach (IMA) will be deferred to 1 January 2028, while all other FRTB components will take effect from 1 January 2027.

---

| | | |
|:---|:---|:---|
| **Capital ratios** | **As at 31.03.26** | **As at 31.12.25** |
| CET1<br>| 14.1%<br>| 14.3%<br>|
| T1<br>| 17.5%<br>| 17.9%<br>|
| Total regulatory capital<br>| 19.7%<br>| 20.4%<br>|
| MREL ratio as a percentage of total RWAs<br>| 35.4%<br>| 35.8%<br>|
| **Own funds and eligible liabilities** | **£m** | **£m** |
| **Total equity excluding non-controlling interests per the balance sheet**<br>| **76668**<br>| **77784**<br>|
| Less: other equity instruments (recognised as AT1 capital)<br>| (12714)<br>| (12725)<br>|
| Adjustment to retained earnings for foreseeable ordinary share dividends<br>| (500)<br>| (778)<br>|
| Adjustment to retained earnings for foreseeable repurchase of shares<br>| (507)<br>| (271)<br>|
| Adjustment to retained earnings for foreseeable other equity coupons<br>| (45)<br>| (36)<br>|
| **Other regulatory adjustments and deductions**<br>|  |  |
| Additional value adjustments (PVA)<br>| (2103)<br>| (1956)<br>|
| Goodwill and intangible assets<br>| (8327)<br>| (8255)<br>|
| Deferred tax assets that rely on future profitability excluding temporary differences<br>| (958)<br>| (1069)<br>|
| Fair value reserves related to gains or losses on cash flow hedges<br>| 2147<br>| 666<br>|
| Excess of expected losses over impairment<br>| (446)<br>| (436)<br>|
| Gains or losses on liabilities at fair value resulting from own credit<br>| 507<br>| 904<br>|
| Defined benefit pension fund assets<br>| (2352)<br>| (2398)<br>|
| Direct and indirect holdings by an institution of own CET1 instruments<br>| (7)<br>| (14)<br>|
| Other regulatory adjustments<br>| (144)<br>| (346)<br>|
| **CET1 capital**<br>| **51219**<br>| **51070**<br>|
| **AT1 capital**<br>|  |  |
| Capital instruments and related share premium accounts<br>| 12758<br>| 12758<br>|
| Other regulatory adjustments and deductions<br>| (44)<br>| (33)<br>|
| **AT1 capital**<br>| **12714**<br>| **12725**<br>|
| **T1 capital**<br>| **63933**<br>| **63795**<br>|
| **T2 capital**<br>|  |  |
| Capital instruments and related share premium accounts<br>| 7937<br>| 8835<br>|
| Qualifying T2 capital (including minority interests) issued by subsidiaries<br>| 53<br>| 55<br>|
| Other regulatory adjustments and deductions<br>| (134)<br>| (71)<br>|
| **Total regulatory capital**<br>| **71789**<br>| **72614**<br>|
| Less : Ineligible T2 capital (including minority interests) issued by subsidiaries<br>| (53)<br>| (55)<br>|
| Eligible liabilities<br>| 57113<br>| 55106<br>|
| **Total own funds and eligible liabilities<sup>1</sup>**<br>| **128850**<br>| **127665**<br>|
| **Total RWAs**<br>| **364462**<br>| **356774**<br>|

---

---

| | |
|:---|:---|
| *1* | *As at 31 March 2026, the Group's MREL requirement, excluding any applicable institution-specific confidential PRA buffer, was to hold £111.2bn of own funds and eligible liabilities equating to 30.5% of RWAs. The Group remains above its MREL regulatory requirement including any applicable institution-specific confidential PRA buffer.* |

---

---

| | |
|:---|:---|
| **Movement in CET1 capital** | **Three months ended 31.03.26** |
|  | £m |
| **Opening CET1 capital** | **51070** |
| Profit for the period attributable to equity holders | 2176 |
| Own credit relating to derivative liabilities | (18) |
| Ordinary share dividends paid and foreseen | (500) |
| Purchased and foreseeable share repurchase | (1000) |
| Other equity coupons paid and foreseen | (254) |
| **Increase in retained regulatory capital generated from earnings** | **404** |
| Net impact of share schemes | (383) |
| Fair value through other comprehensive income reserve | (39) |
| Currency translation reserve | 353 |
| Other reserves | (5) |
| **Decrease in other qualifying reserves** | **(74)** |
| Pension remeasurements within reserves | (66) |
| Defined benefit pension fund asset deduction | 47 |
| **Net impact of pensions** | **(19)** |
| Additional value adjustments (PVA) | (147) |
| Goodwill and intangible assets | (72) |
| Deferred tax assets that rely on future profitability excluding those arising from temporary differences | 111 |
| Excess of expected loss over impairment | (10) |
| Direct and indirect holdings by an institution of own CET1 instruments | 7 |
| Other regulatory adjustments | (51) |
| **Decrease in regulatory capital due to adjustments and deductions** | **(162)** |
| **Closing CET1 capital** | **51219** |

---

CET1 capital increased by £0.1bn to £51.2bn (December 2025: £51.1bn). Significant movements in the period were:

- £1.0bn share buybacks announced with FY25 results

- £0.5bn accrual towards the total 2026 dividend

- £0.3bn of equity coupons paid and foreseen

● £0.1bn
decrease in other qualifying reserves including a £0.4bn
decrease from the net impact of employee share schemes, partially
offset by a £0.4bn increase in the currency translation
reserve as a result of foreign exchange movements

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** | **RWAs by risk type and business** |
|  | **Credit risk** | **Credit risk** | **Counterparty credit risk** | **Counterparty credit risk** | **Counterparty credit risk** | **Counterparty credit risk** | **Market Risk** | **Market Risk** | **Operational risk** | **Total RWAs** |
|  | **STD** | **IRB** | **STD** | **IRB** | **Settlement Risk** | **CVA** | **STD** | **IMA** |  |  |
| **As at 31.03.26** | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| Barclays UK<br>| 16737<br>| 56662<br>| 117<br>| 9<br>| -<br>| 37<br>| 118<br>| -<br>| 13804<br>| 87484<br>|
| Barclays UK Corporate Bank<br>| 4097<br>| 18921<br>| 87<br>| 267<br>| -<br>| 3<br>| 19<br>| 330<br>| 3530<br>| 27254<br>|
| Barclays Private Bank & Wealth Management<br>| 5020<br>| 678<br>| 124<br>| 30<br>| 1<br>| 11<br>| 32<br>| 225<br>| 2062<br>| 8183<br>|
| Barclays Investment Bank<br>| 42919<br>| 51782<br>| 24119<br>| 21504<br>| 243<br>| 2522<br>| 11978<br>| 21380<br>| 25275<br>| 201722<br>|
| Barclays US Consumer Bank<br>| 21158<br>| 1017<br>| -<br>| -<br>| -<br>| -<br>| -<br>| -<br>| 5394<br>| 27569<br>|
| Head Office<br>| 5441<br>| 5482<br>| -<br>| -<br>| -<br>| -<br>| 237<br>| -<br>| 1090<br>| 12250<br>|
| **Barclays Group**<br>| **95372**<br>| **134542**<br>| **24447**<br>| **21810**<br>| **244**<br>| **2573**<br>| **12384**<br>| **21935**<br>| **51155**<br>| **364462**<br>|
| **As at 31.12.25** |  |  |  |  |  |  |  |  |  |  |
| Barclays UK<br>| 16731<br>| 55037<br>| 132<br>| 8<br>| -<br>| 43<br>| 177<br>| -<br>| 13697<br>| 85825<br>|
| Barclays UK Corporate Bank<br>| 3878<br>| 18341<br>| 89<br>| 312<br>| 1<br>| 4<br>| 31<br>| 343<br>| 3510<br>| 26509<br>|
| Barclays Private Bank & Wealth Management<br>| 4981<br>| 580<br>| 112<br>| 19<br>| -<br>| 11<br>| 39<br>| 240<br>| 2054<br>| 8036<br>|
| Barclays Investment Bank<br>| 44961<br>| 49750<br>| 21986<br>| 19442<br>| 165<br>| 3030<br>| 12018<br>| 20111<br>| 25238<br>| 196701<br>|
| Barclays US Consumer Bank<br>| 21050<br>| 1004<br>| -<br>| 1<br>| -<br>| -<br>| -<br>| -<br>| 5393<br>| 27448<br>|
| Head Office<br>| 5405<br>| 5439<br>| 1<br>| 5<br>| -<br>| -<br>| 219<br>| 59<br>| 1127<br>| 12255<br>|
| **Barclays Group**<br>| **97006**<br>| **130151**<br>| **22320**<br>| **19787**<br>| **166**<br>| **3088**<br>| **12484**<br>| **20753**<br>| **51019**<br>| **356774**<br>|

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Movement analysis of RWAs** | **Credit risk** | **Counterparty credit risk** | **Market risk** | **Operational risk** | **Total RWAs** |
|  | £m | £m | £m | £m | £m |
| **RWAs as at 31.12.25**<br>| **227157**<br>| **45361**<br>| **33237**<br>| **51019**<br>| **356774**<br>|
| Book size<br>| 1440<br>| 3154<br>| 895<br>| 136<br>| 5625<br>|
| Acquisitions and disposals<br>| -<br>| -<br>| -<br>| -<br>| -<br>|
| Book quality<br>| (72)<br>| (12)<br>| -<br>| -<br>| (84)<br>|
| Model updates<br>| -<br>| -<br>| -<br>| -<br>| -<br>|
| Methodology and policy<br>| 6<br>| -<br>| -<br>| -<br>| 6<br>|
| Foreign exchange movements<sup>1</sup><br>| 1383<br>| 571<br>| 187<br>| -<br>| 2141<br>|
| **Total RWA movements** | **2757** | **3713** | **1082** | **136** | **7688** |
| **RWAs as at 31.03.26**<br>| **229914**<br>| **49074**<br>| **34319**<br>| **51155**<br>| **364462**<br>|

---

 *1* *Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.*

Total RWAs increased £7.7bn to £364.5bn (Dec 2025: £356.8bn).

Credit risk RWAs increased £2.8bn:

● A
£2.8bn increase primarily reflecting lending growth in UK
businesses and the impact of foreign exchange
movements

Counterparty credit risk RWAs increased £3.7bn:

● A
£3.7bn increase primarily driven by higher activity within
Global Markets and the impact of foreign exchange
movements

---

| | | |
|:---|:---|:---|
| **Leverage ratios** | **As at 31.03.26** | **As at 31.12.25** |
| **Leverage ratios** | £m | £m |
| UK leverage ratio<sup>1</sup><br>| 4.8%<br>| 5.1%<br>|
| T1 capital<br>| 63933<br>| 63795<br>|
| UK leverage exposure<br>| 1321321<br>| 1247313<br>|
| Average UK leverage ratio<br>| 4.6%<br>| 4.7%<br>|
| Average T1 capital<br>| 63239<br>| 63277<br>|
| Average UK leverage exposure<br>| 1373842<br>| 1358364<br>|

---

---

| | |
|:---|:---|
| *1* | *Although the leverage ratio is expressed in terms of T1 capital, the leverage ratio buffers and 75% of the minimum requirement must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £7.0bn and against the 0.3% CCLB was £4.0bn.* |

---

● The
UK leverage ratio decreased to 4.8% (December 2025: 5.1%) as the
leverage exposure increased by £74.0bn to £1,321.3bn
(December 2025: £1,247.3bn). The increase in leverage exposure
was primarily driven by higher activity in Global
Markets.

 **Condensed Consolidated Financial Statements**

---

| | | |
|:---|:---|:---|
| **Condensed consolidated income statement (unaudited)** | **Condensed consolidated income statement (unaudited)** | **Condensed consolidated income statement (unaudited)** |
|  | **Three months**<br> **ended**<br> **31.03.26** | **Three months**<br> **ended**<br> **31.03.25** |
|  | £m | £m |
| **Total income** | **8163** | **7709** |
| Operating expenses excluding UK regulatory levies & litigation and conduct<br>| (4359) | (4258) |
| UK regulatory levies<br>| (84) | (96) |
| Litigation and conduct | (104) | (11) |
| **Operating expenses** | **(4547)** | **(4365)** |
| Other net income | 21 | 18 |
| **Profit before impairment** | **3637** | **3362** |
| Credit impairment charges | (823) | (643) |
| **Profit before tax** | **2814** | **2719** |
| Tax charge | (638) | (621) |
| **Profit after tax** | **2176** | **2098** |
| **Attributable to:** |  |  |
| Shareholders of the parent | 1932 | 1864 |
| Other equity holders | 244 | 232 |
| **Equity holders of the parent** | **2176** | **2096** |
| Non-controlling interests | - | 2 |
| **Profit after tax** | **2176** | **2098** |
| **Earnings per share** |  |  |
| Basic earnings per ordinary share<br>| 14.1p<br>| 13.0p<br>|

---

---

| | | |
|:---|:---|:---|
| **Condensed consolidated balance sheet (unaudited)** | **Condensed consolidated balance sheet (unaudited)** | **Condensed consolidated balance sheet (unaudited)** |
|  | **As at 31.03.26** | **As at 31.12.25** |
| **Assets** | £m | £m |
| Cash and balances at central banks | 235350 | 229752 |
| Cash collateral and settlement balances | 197420 | 130532 |
| Debt securities at amortised cost | 68325 | 68475 |
| Loans and advances at amortised cost to banks | 11996 | 8638 |
| Loans and advances at amortised cost to customers | 358306 | 352885 |
| Reverse repurchase agreements and other similar secured lending at amortised cost | 11556 | 17622 |
| Trading portfolio assets | 191053 | 190061 |
| Financial assets at fair value through the income statement | 218729 | 186857 |
| Derivative financial instruments | 286388 | 252459 |
| Financial assets at fair value through other comprehensive income | 83095 | 74394 |
| Investments in associates and joint ventures | 760 | 739 |
| Goodwill and intangible assets | 8357 | 8284 |
| Current tax assets | 228 | 276 |
| Deferred tax assets | 5412 | 4992 |
| Assets included in a disposal group classified as held for sale | 5555 | 5932 |
| Other assets | 12256 | 12267 |
| **Total assets** | **1694786** | **1544165** |
| **Liabilities** |  |  |
| Deposits at amortised cost from banks | 19739 | 20413 |
| Deposits at amortised cost from customers | 567855 | 565200 |
| Cash collateral and settlement balances | 174566 | 117583 |
| Repurchase agreements and other similar secured borrowings at amortised cost | 27874 | 25170 |
| Debt securities in issue | 124647 | 119033 |
| Subordinated liabilities | 12192 | 12954 |
| Trading portfolio liabilities | 82911 | 57737 |
| Financial liabilities designated at fair value | 321632 | 294108 |
| Derivative financial instruments | 272778 | 240808 |
| Current tax liabilities | 1167 | 868 |
| Deferred tax liabilities | 13 | 13 |
| Liabilities included in a disposal group classified as held for sale | - | - |
| Other liabilities | 12292 | 12042 |
| **Total liabilities** | **1617666** | **1465929** |
| **Equity** |  |  |
| Called up share capital and share premium | 4218 | 4178 |
| Other reserves | 891 | 1628 |
| Retained earnings | 58845 | 59253 |
| **Shareholders' equity attributable to ordinary shareholders of the parent** | **63954** | **65059** |
| Other equity instruments | 12714 | 12725 |
| **Total equity excluding non-controlling interests** | **76668** | **77784** |
| Non-controlling interests | 452 | 452 |
| **Total equity** | **77120** | **78236** |
| **Total liabilities and equity** | **1694786** | **1544165** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** | **Condensed consolidated statement of changes in equity (unaudited)** |
|  | **Called up share capital and share premium** | **Other equity instruments** | **Other reserves** | <br> **Retained earnings** | <br> **Total** | **Non-controlling interests** | <br> **Total equity** |
| **Three months ended 31.03.2026** | £m | £m | £m | £m | £m | £m | £m |
| **Balance as at 1 January 2026** | **4178** | **12725** | **1628** | **59253** | **77784** | **452** | **78236** |
| Profit after tax | - | 244 | - | 1932 | 2176 | - | 2176 |
| Currency translation movements | - | - | 353 | - | 353 | - | 353 |
| Fair value through other comprehensive income reserve | - | - | (39) | - | (39) | - | (39) |
| Cash flow hedges | - | - | (1481) | - | (1481) | - | (1481) |
| Retirement benefit remeasurements | - | - | - | (66) | (66) | - | (66) |
| Own credit | - | - | 378 | - | 378 | - | 378 |
| **Total comprehensive income for the period** | **-** | **244** | **(789)** | **1866** | **1321** | **-** | **1321** |
| Employee share schemes and hedging thereof | 81 | - | - | 195 | 276 | - | 276 |
| Issue and redemption of other equity instruments | - | - | - | - | - | - | - |
| Other equity instruments coupon paid | - | (244) | - | - | (244) | - | (244) |
| Redemption of preference shares | - | - | - | - | - | - | - |
| Vesting of employee share schemes net of purchases | - | - | 7 | (927) | (920) | - | (920) |
| Dividends paid | - | - | - | (769) | (769) | - | (769) |
| Repurchase of shares | (41) | - | 41 | (768) | (768) | - | (768) |
| Other movements | - | (11) | 4 | (5) | (12) | - | (12) |
| **Balance as at 31 March 2026** | **4218** | **12714** | **891** | **58845** | **76668** | **452** | **77120** |

---

---

| | | |
|:---|:---|:---|
|  | **As at 31.03.26** | **As at 31.12.25** |
| **Other Reserves** | £m | £m |
| Currency translation reserve<br>| 2846 | 2493 |
| Fair value through other comprehensive income reserve<br>| (1139) | (1100) |
| Cash flow hedging reserve<br>| (2147) | (666) |
| Own credit reserve<br>| (608) | (990) |
| Other reserves and treasury shares | 1939 | 1891 |
| **Total**<br>| **891** | **1628** |

---

 **Appendix: Non-IFRS Performance Measures**

The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements, as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 **Non-IFRS performance measures glossary**

---

| | |
|:---|:---|
| **Measure** | **Definition** |
| Loan: deposit ratio<br>| Total loans and advances at amortised cost divided by total deposits at amortised cost.<br>|
| **Period end tangible equity refers to:** | **Period end tangible equity refers to:** |
| Period end tangible shareholders' equity (for Barclays Group)<br>| Shareholders' equity attributable to ordinary shareholders of the parent, adjusted for the deduction of goodwill and intangible assets.<br>|
| Period end allocated tangible equity (for businesses)<br>| Allocated tangible equity is calculated as 13.5% (2025: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group's tangible shareholders' equity and the amounts allocated to businesses.<br>|
| **Average tangible equity refers to:** | **Average tangible equity refers to:** |
| Average tangible shareholders' equity (for Barclays Group)<br>| Calculated as the average of the previous month's period end tangible shareholders' equity and the current month's period end tangible shareholders' equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period.<br>|
| Average allocated tangible equity (for businesses)<br>| Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.<br>|
| **Return on tangible equity (RoTE) refers to:** | **Return on tangible equity (RoTE) refers to:** |
| Return on average tangible shareholders' equity (for Barclays Group)<br>| Annualised Group attributable profit, as a proportion of average tangible shareholders' equity. The components of the calculation have been included on page 41.<br>|
| Return on average allocated tangible equity (for businesses)<br>| Annualised business attributable profit, as a proportion of that business's average allocated tangible equity. The components of the calculation have been included on pages 42 to 43.<br>|
| Operating costs<br>| A measure of total operating expenses excluding litigation and conduct charges and UK regulatory levies.<br>|
| Cost: income ratio<br>| Total operating expenses divided by total income.<br>|
| Loan loss rate<br>| Quoted in basis points and represents total impairment charges divided by total gross loans and advances held at amortised cost (including portfolios reclassified to assets held for sale) at the balance sheet date. The components of the calculation have been included on pages 44 to 46.<br>|
| Net interest margin<br>| Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 23.<br>|
| Tangible net asset value per share<br>| Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 48.<br>|
| Profit before impairment<br>| Calculated by excluding credit impairment charges or releases from profit before tax.<br>|
| Net New Assets Under Management<br>| The net inflows and outflows of client balances within Discretionary Portfolio Management and Advisory mandates. Excludes market performance and foreign exchange translation but includes reinvested dividend payments.<br>|
| Assets under Management (AUM)<br>| Total market value of client investment balances managed within investment mandates where Barclays provides discretionary portfolio management or advisory services. Total Assets Under Management excludes uninvested cash held under an investment mandate and reported within deposits.<br>|
| Assets under Supervision (AUS)<br>| Total market value of client investment balances where Barclays provides custodian or transactional services.<br>|
| Group net interest income excluding Barclays Investment Bank and Head Office<br>| A measure of Barclays Group net interest income, excluding the net interest income reported in Barclays Investment Bank and Head Office.<br>|
| Income over average risk weighted assets<br>| Represents total income as a proportion of average risk weighted assets. Average risk weighted assets calculated as the average of the previous month's period end risk weighted assets and the<br> current month's period end risk weighted assets. Average risk weighted assets for the period is the average of the monthly averages within that period.<br>|

---

 **Returns**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** |  |
|  | **Barclays UK** | **Barclays UK Corporate Bank** | **Barclays Private Bank and Wealth Management** | <br>**Barclays Investment Bank** | **Barclays US Consumer Bank** | **Head Office** | **Barclays Group** |
| **Return on average tangible equity**<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>|
| Attributable profit/(loss) | 591 | 187 | 73 | 1111 | 176 | (206) | 1932 |
|  | £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>|
| Average equity | 15.9 | 3.8 | 1.2 | 29.7 | 4.3 | 10.6 | 65.5 |
| Average goodwill and intangibles | (3.9) | - | (0.1) | - | (0.5) | (3.8) | (8.3) |
| **Average tangible equity** | **12.0**<br>| **3.8**<br>| **1.1**<br>| **29.7**<br>| **3.8**<br>| **6.8**<br>| **57.2**<br>|
| **Return on average tangible equity** | **19.7%** | **19.9%** | **25.5%** | **15.0%** | **18.8%** | **n/m** | **13.5%** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** |  |
|  | **Barclays UK** | **Barclays UK Corporate Bank** | **Barclays Private Bank and Wealth Management** | **Barclays Investment Bank** | **Barclays US Consumer Bank** | **Head Office** | **Barclays Group** |
| **Return on average tangible equity**<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>|
| Attributable profit/(loss) | 510 | 142 | 96 | 1199 | 41 | (124) | 1864 |
|  | £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>|
| Average equity | 15.7 | 3.3 | 1.2 | 29.6 | 4.2 | 7.4 | 61.4 |
| Average goodwill and intangibles | (4.0) | - | (0.1) | - | (0.6) | (3.6) | (8.3) |
| **Average tangible equity** | **11.7**<br>| **3.3**<br>| **1.1**<br>| **29.6**<br>| **3.6**<br>| **3.8**<br>| **53.1**<br>|
| **Return on average tangible equity** | **17.4%** | **17.1%** | **34.5%** | **16.2%** | **4.5%** | **n/m** | **14.0%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Group** |  |  |  |  |  |  |  |  |
| **Return on average tangible shareholders' equity** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Return on average tangible shareholders' equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 1932 | 1195 | 1457 | 1659 | 1864 | 965 | 1564 | 1237 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average shareholders' equity | 65.5 | 64.8 | 63.3 | 62.1 | 61.4 | 59.7 | 59.1 | 57.7 |
| Average goodwill and intangibles | (8.3) | (8.3) | (8.2) | (8.2) | (8.3) | (8.2) | (8.1) | (7.9) |
| **Average tangible shareholders' equity** | **57.2** | **56.5** | **55.1** | **53.9** | **53.1** | **51.5** | **51.0** | **49.8** |
| **Return on average tangible shareholders' equity** | **13.5%** | **8.5%** | **10.6%** | **12.3%** | **14.0%** | **7.5%** | **12.3%** | **9.9%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 591 | 706 | 647 | 580 | 510 | 781 | 621 | 584 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average allocated equity | 15.9 | 15.9 | 15.9 | 15.8 | 15.7 | 15.1 | 14.5 | 14.4 |
| Average goodwill and intangibles | (3.9) | (4.0) | (4.0) | (4.0) | (4.0) | (3.9) | (3.9) | (3.9) |
| **Average allocated tangible equity** | **12.0** | **11.9** | **11.9** | **11.8** | **11.7** | **11.2** | **10.6** | **10.5** |
| **Return on average allocated tangible equity** | **19.7%** | **23.8%** | **21.8%** | **19.7%** | **17.4%** | **28.0%** | **23.4%** | **22.3%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK Corporate Bank** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 187 | 168 | 196 | 142 | 142 | 98 | 144 | 135 |
|  | £bn<br>| £bn<br>| £bn | £bn | £bn<br>| £bn<br>| £bn | £bn |
| Average allocated equity | 3.8 | 3.5 | 3.4 | 3.4 | 3.3 | 3.2 | 3.1 | 3.0 |
| Average goodwill and intangibles | - | - | - | - | - | - | - | - |
| **Average allocated tangible equity** | **3.8** | **3.5** | **3.4** | **3.4** | **3.3** | **3.2** | **3.1** | **3.0** |
| **Return on average allocated tangible equity** | **19.9%** | **19.1%** | **22.8%** | **16.6%** | **17.1%** | **12.3%** | **18.8%** | **18.0%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Private Bank and Wealth Management** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 73 | 35 | 72 | 88 | 96 | 63 | 74 | 77 |
|  | £bn | £bn | £bn | £bn | £bn<br>| £bn<br>| £bn<br>| £bn |
| Average allocated equity | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 |
| Average goodwill and intangibles | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) |
| **Average allocated tangible equity** | **1.1** | **1.1** | **1.1** | **1.1** | **1.1** | **1.1** | **1.0** | **1.0** |
| **Return on average allocated tangible equity** | **25.5%** | **12.6%** | **26.4%** | **31.9%** | **34.5%** | **23.9%** | **29.0%** | **30.8%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Investment Bank** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 1111 | 294 | 723 | 876 | 1199 | 247 | 652 | 715 |
|  | £bn<br>| £bn<br>| £bn<br>| £bn | £bn<br>| £bn<br>| £bn<br>| £bn |
| Average allocated equity | 29.7 | 29.6 | 28.6 | 28.7 | 29.6 | 29.3 | 29.5 | 29.9 |
| Average goodwill and intangibles | - | - | - | - | - | - | - | - |
| **Average allocated tangible equity** | **29.7** | **29.6** | **28.6** | **28.7** | **29.6** | **29.3** | **29.5** | **29.9** |
| **Return on average allocated tangible equity** | **15.0%** | **4.0%** | **10.1%** | **12.2%** | **16.2%** | **3.4%** | **8.8%** | **9.6%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays US Consumer Bank** |  |  |  |  |  |  |  |  |
| **Return on average allocated tangible equity** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Return on average allocated tangible equity** | £m | £m | £m | £m | £m | £m | £m | £m |
| Attributable profit | 176 | 144 | 118 | 87 | 41 | 94 | 89 | 75 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average allocated equity | 4.3 | 4.2 | 4.0 | 4.0 | 4.2 | 4.0 | 3.8 | 3.6 |
| Average goodwill and intangibles | (0.5) | (0.6) | (0.5) | (0.6) | (0.6) | (0.6) | (0.5) | (0.3) |
| **Average allocated tangible equity** | **3.8** | **3.6** | **3.5** | **3.4** | **3.6** | **3.4** | **3.3** | **3.3** |
| **Return on average allocated tangible equity** | **18.8%** | **15.8%** | **13.5%** | **10.2%** | **4.5%** | **11.2%** | **10.9%** | **9.2%** |

---

 **Loan loss rates**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** | **Three months ended 31.03.26** |  |
|  | **Barclays UK** | **Barclays UK Corporate Bank** | **Barclays Private Bank and Wealth Management** | **Barclays Investment Bank** | **Barclays US Consumer Bank** | **Head Office** | **Barclays Group** |
| **Loan loss rate**<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>|
| Credit impairment (charges)/ releases | (178) | (3) | 2 | (279) | (367) | 2 | (823) |
|  | £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>|
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)<sup>1</sup> | 233.6 | 31.0 | 15.1 | 137.4 | 30.3 | 2.4 | 449.9 |
| **Loan loss rate (bps)** | **31** | **4** | **(6)** | **82** | **491** | **n/m** | **74** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** | **Three months ended 31.03.25** |  |
|  | **Barclays UK** | **Barclays UK Corporate Bank** | **Barclays Private Bank and Wealth Management** | **Barclays Investment Bank** | **Barclays US Consumer Bank** | **Head Office** | **Barclays Group** |
| **Loan loss rate** | £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>| £m<br>|
| Credit impairment (charges)/releases | (158) | (19) | 9 | (72) | (399) | (4) | (643) |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)<sup>1</sup> | 227.5 | 27.0 | 14.8 | 129.6 | 28.9 | 2.6 | 430.4 |
| **Loan loss rate (bps)** | **28** | **28** | **(25)** | **23** | **562** | **n/m** | **61** |

---

 *1* *Includes gross loans and advances to customers and banks, in addition to debt securities.*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Group** |  |  |  |  |  |  |  |  |
| **Loan loss rate** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Loan loss rate** | £m | £m | £m | £m | £m | £m | £m | £m |
| Credit impairment charges | (823) | (535) | (632) | (469) | (643) | (711) | (374) | (384) |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) | 449.9 | 441.3 | 437.5 | 428.4 | 430.4 | 429.6 | 408.3 | 409.1 |
| **Loan loss rate (bps)** | **74** | **48** | **57** | **44** | **61** | **66** | **37** | **38** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK** |  |  |  |  |  |  |  |  |
| **Loan loss rate** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Loan loss rate** | £m | £m | £m | £m | £m | £m | £m | £m |
| Credit impairment charges | (178) | (74) | (102) | (79) | (158) | (283) | (16) | (8) |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) | 233.6 | 231.9 | 230.9 | 228.5 | 227.5 | 227.5 | 218.4 | 217.3 |
| **Loan loss rate (bps)** | **31** | **13** | **18** | **14** | **28** | **49** | **3** | **1** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays UK Corporate Bank** |  |  |  |  |  |  |  |  |
| **Loan loss rate** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Loan loss rate** | £m | £m | £m | £m | £m | £m | £m | £m |
| Credit impairment charges | (3) | (1) | (5) | (12) | (19) | (40) | (13) | (8) |
|  | £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>|
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) | 31.0 | 30.2 | 29.2 | 28.2 | 27.0 | 25.8 | 25.2 | 26.0 |
| **Loan loss rate (bps)** | **4** | **1** | **7** | **17** | **28** | **62** | **21** | **12** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Private Bank and Wealth Management** |  |  |  |  |  |  |  |  |
| **Loan loss rate** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Loan loss rate** | £m | £m | £m | £m | £m | £m | £ | £m |
| Credit impairment releases/(charges) | 2 | (2) | (1) | 2 | 9 | (2) | (7) | 3 |
|  | £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>| £bn<br>|
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) | 15.1 | 15.1 | 15.2 | 14.8 | 14.8 | 14.7 | 14.3 | 14.1 |
| **Loan loss rate (bps)** | **(6)** | **5** | **3** | **(5)** | **(25)** | **5** | **19** | **(9)** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Investment Bank** |  |  |  |  |  |  |  |  |
| **Loan loss rate** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Loan loss rate** | £m | £m | £m | £m | £m | £m | £m | £m |
| Credit impairment charges | (279) | (22) | (144) | (67) | (72) | (46) | (43) | (44) |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) | 137.4 | 131.0 | 129.8 | 126.8 | 129.6 | 124.9 | 116.5 | 115.5 |
| **Loan loss rate (bps)** | **82** | **7** | **44** | **21** | **23** | **15** | **15** | **15** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays US Consumer Bank** |  |  |  |  |  |  |  |  |
| **Loan loss rate** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Loan loss rate** | £m | £m | £m | £m | £m | £m | £m | £m |
| Credit impairment charges | (367) | (431) | (379) | (312) | (399) | (298) | (276) | (309) |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) | 30.3 | 30.6 | 29.8 | 27.4 | 28.9 | 30.0 | 26.7 | 28.4 |
| **Loan loss rate (bps)** | **491** | **558** | **505** | **456** | **562** | **395** | **411** | **438** |

---

 **Income over average RWAs**

---

| | | |
|:---|:---|:---|
| **Barclays Investment Bank** | **Three months ended 31.03.26** | **Three months ended 31.03.25** |
| **Barclays Investment Bank** | £m | £m |
| Income | 4028 | 3873 |
|  | £bn | £bn |
| Average RWAs | 202.0 | 201.4 |
| **Income over average RWAs** | **8.0%** | **7.7%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Barclays Investment Bank** | **Q126** | **Q425** | **Q325** | **Q225** | **Q125** | **Q424** | **Q324** | **Q224** |
| **Barclays Investment Bank** | £m | £m | £m | £m | £m | £m | £m | £m |
| Income | 4028 | 2792 | 3083 | 3307 | 3873 | 2607 | 2851 | 3019 |
|  | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn |
| Average RWAs | 202.0 | 202.1 | 194.9 | 196.1 | 201.4 | 199.9 | 201.8 | 204.9 |
| **Income over average RWAs** | **8.0%** | **5.5%** | **6.3%** | **6.7%** | **7.7%** | **5.2%** | **5.7%** | **5.9%** |

---

---

| | | | |
|:---|:---|:---|:---|
| **Tangible net asset value per share** | **As at 31.03.26** | **As at 31.12.25** | **As at 31.03.25** |
|  | £m | £m | £m |
| Total equity excluding non-controlling interests | 76668 | 77784 | 74880 |
| Other equity instruments | (12714) | (12725) | (13263) |
| Goodwill and intangibles | (8357) | (8284) | (8250) |
| **Tangible shareholders' equity attributable to ordinary shareholders of the parent** | **55597** | **56775** | **53367** |
|  | m | m | m |
| **Shares in issue** | 13737 | 13867 | 14336 |
|  | p | p | p |
| **Tangible net asset value per share** | **405** | **409** | **372** |

---

 **Shareholder Information**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Results timetable<sup>1</sup>** |  |  |  | **Date** |  |
| 2026 Interim Results Announcement |  |  |  | 28 July 2026 | 28 July 2026 |
|  |  |  |  | **% Change<sup>2</sup>** | **% Change<sup>2</sup>** |
| **Exchange rates** | **31.03.26** | **31.12.25** | **31.03.25** | **31.12.25** | **31.03.25** |
| Period end - GBP/USD | 1.32 | 1.34 | 1.29 | (2)% | 2% |
| 3 month average - GBP/USD | 1.35 | 1.33 | 1.26 | 1% | 7% |
| Period end - GBP/EUR | 1.15 | 1.15 | 1.19 | -% | (4)% |
| 3 month average - GBP/EUR | 1.15 | 1.14 | 1.20 | 1% | (4)% |
| **Share price data** |  |  |  |  |  |
| Barclays PLC (p) | 389 | 476 | 288 |  |  |
| Barclays PLC number of shares (m)<sup>3</sup> | 13737 | 13867 | 14336 |  |  |
| **For further information please contact** | **For further information please contact** |  |  |  |  |
| **Investor relations** | **Media relations** | **Media relations** | **Media relations** | **Media relations** | **Media relations** |
| Marina Shchukina +44 (0) 20 7116 2526 | Tom Hoskin +44 (0) 20 7116 4755 | Tom Hoskin +44 (0) 20 7116 4755 | Tom Hoskin +44 (0) 20 7116 4755 | Tom Hoskin +44 (0) 20 7116 4755 | Tom Hoskin +44 (0) 20 7116 4755 |
| More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays | More information on Barclays can be found on our website: home.barclays |
| **Registered office** |  |  |  |  |  |
| 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. |
| **Registrar** |  |  |  |  |  |
| Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. |
| Tel: +44 (0)371 384 2055 (UK and International telephone number)<sup>4</sup>. | Tel: +44 (0)371 384 2055 (UK and International telephone number)<sup>4</sup>. | Tel: +44 (0)371 384 2055 (UK and International telephone number)<sup>4</sup>. | Tel: +44 (0)371 384 2055 (UK and International telephone number)<sup>4</sup>. | Tel: +44 (0)371 384 2055 (UK and International telephone number)<sup>4</sup>. | Tel: +44 (0)371 384 2055 (UK and International telephone number)<sup>4</sup>. |
| **American Depositary Receipts (ADRs)** |  |  |  |  |  |
| Shareowner Services | Shareowner Services | Shareowner Services | Shareowner Services | Shareowner Services | Shareowner Services |
| P.O. Box 64504 | P.O. Box 64504 | P.O. Box 64504 | P.O. Box 64504 | P.O. Box 64504 | P.O. Box 64504 |
| St. Paul, MN 55164-0504 | St. Paul, MN 55164-0504 | St. Paul, MN 55164-0504 | St. Paul, MN 55164-0504 | St. Paul, MN 55164-0504 | St. Paul, MN 55164-0504 |
| United States of America | United States of America | United States of America | United States of America | United States of America | United States of America |
| shareowneronline.com | shareowneronline.com | shareowneronline.com | shareowneronline.com | shareowneronline.com | shareowneronline.com |
| Toll Free Number (US and Canada): +1 800-990-1135 | Toll Free Number (US and Canada): +1 800-990-1135 | Toll Free Number (US and Canada): +1 800-990-1135 | Toll Free Number (US and Canada): +1 800-990-1135 | Toll Free Number (US and Canada): +1 800-990-1135 | Toll Free Number (US and Canada): +1 800-990-1135 |
| Outside the US and Canada: +1 651-453-2128 | Outside the US and Canada: +1 651-453-2128 | Outside the US and Canada: +1 651-453-2128 | Outside the US and Canada: +1 651-453-2128 |  |  |
| Delivery of ADR certificates and overnight mail | Delivery of ADR certificates and overnight mail |  |  |  |  |
| Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. | Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. |

---

---

| | |
|:---|:---|
| *1* | *Note that this date is provisional and subject to change.* |
| *2* | *The change is the impact to GBP reported information.* |
| *3* | *The number of shares of 13,737m as at 31 March 2026 is different from the 13,725m quoted in the 1 April 2026 announcement entitled "Total Voting Rights" because the share buyback transactions executed on 30 and 31 March 2026 did not settle until 1 and 2 April 2026 respectively.* |
| *4* | *Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.* |

---

&#xD; &#xD; &amp;#xD;&#xD; &#xD; &#xD;